Analytici očekávají, že AT&T vykáže čtvrtletní zisk ve výši 0,61 USD na akcii, což by znamenalo meziroční nárůst o 13 %, při tržbách 31,68 miliardy USD.
Wall Street analysts expect AT&T (T - Free Report) to post quarterly earnings of $0.61 per share in its upcoming report, which indicates a year-over-year increase of 13%. Revenues are expected to be $31.68 billion, up 3.2% from the year-ago quarter.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 4.4% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some AT&T metrics that are commonly tracked and projected by analysts on Wall Street.
Based on the collective assessment of analysts, 'Operating Revenues- Corporate and Other' should arrive at $92.53 million. The estimate indicates a year-over-year change of -5.6%.
The collective assessment of analysts points to an estimated 'Operating Revenues- Latin America' of $1.15 billion. The estimate suggests a change of +5.4% year over year.
The combined assessment of analysts suggests that 'Revenues- Latin America- Wireless equipment' will likely reach $454.10 million. The estimate suggests a change of +13.8% year over year.
The consensus among analysts is that 'Revenues- Latin America- Wireless service' will reach $654.66 million. The estimate indicates a year-over-year change of -5.9%.
Analysts' assessment points toward 'Retail Wireless Net Adds- Phone - Postpaid' reaching 365.63 thousand. Compared to the current estimate, the company reported 328.00 thousand in the same quarter of the previous year.
The average prediction of analysts places 'Retail Wireless Subscribers- Phone - Postpaid' at 75.29 million. The estimate compares to the year-ago value of 90.26 million.
It is projected by analysts that the 'Retail Wireless Subscribers- Phone' will reach 91.73 million. Compared to the current estimate, the company reported 73.80 million in the same quarter of the previous year.
Analysts predict that the 'Internet Connections - Fiber' will reach 13.26 million. Compared to the present estimate, the company reported 10.12 million in the same quarter last year.
The consensus estimate for 'Internet Net Adds - Fiber' stands at 390.00 thousand. Compared to the current estimate, the company reported 288.00 thousand in the same quarter of the previous year.
Analysts expect 'Internet Connections - Fixed Wireless' to come in at 2.91 million. The estimate compares to the year-ago value of 4.37 million.
Analysts forecast 'Retail Wireless Subscribers- Phone - Prepaid' to reach 16.45 million. Compared to the current estimate, the company reported 18.54 million in the same quarter of the previous year.
According to the collective judgment of analysts, 'Internet Net Adds - AT&T Internet Air (AIA)' should come in at 238.33 thousand. The estimate is in contrast to the year-ago figure of 270.00 thousand.
View all Key Company Metrics for AT&T here>>>
Over the past month, AT&T shares have recorded returns of -7.4% versus the Zacks S&P 500 composite's +2.4% change. Based on its Zacks Rank #3 (Hold), T will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Jamie Dimon varoval, že vysoké fiskální deficity, přetrvávající inflace, drahá aktiva, rostoucí úrokové sazby a geopolitické napětí mohou ohrozit ekonomiku i tržní aktivitu.
JPMorgan Chase's (JPM +2.21%) third-quarter earnings missed the mark this week, and its stock fell after the report. However, it had already been falling due to interest rate drama, and the results were more mediocre than catastrophic.
Beyond the third quarter, though, CEO Jamie Dimon warned of many moving pieces that could impact the bank and the economy in the coming months. Here's what he said.
The biggest bank in the country
Dimon has the status of leading the biggest bank in the U.S., which is why people pay attention to his insider opinion on what's happening in finance. The bank's performance is also a good proxy for the state of banking.
Overall, the big banks -- many of which have already reported third-quarter earnings -- have demonstrated solid growth. Much of the commercial activity is benefiting from unceasing artificial intelligence (AI) spending as hyperscalers continue their build-out, and the markets segment is still getting a boost from robust investing activity. Dimon noted, however, that activity was already moderating in the third quarter.
JPMorgan Chase CEO Jamie Dimon. Image source: JPMorgan Chase.
The third quarter was bound to see a slowdown from the second quarter, which featured the Space Exploration Technologies initial public offering (IPO), the biggest IPO ever. In the commercial and investment banking (CIB) segment, JPMorgan Chase's revenue increased 14% year over year, but it was down 8% from last quarter. The company had already signaled the slowdown at the Barclays Global Financial Services Conference in September, when Co-President Doug Petno said that the company expected a mid-teens increase, and the stock dropped at the time.
Significantly, earnings per share (EPS) were $5.57, falling short of the $5.93 expected by Wall Street, while total revenue increased 8% to $50.17 billion, lower than the $51.23 billion Wall Street wanted.
It's a testament to the market's confidence in the bank that the stock didn't fall further after the report. It's already down 10% over the past few weeks due to the previous update, as well as bond market and interest rate volatility weighing on its price.
"We just don't know when it's going to stop"
Dimon echoed his previous sentiment that the bank is enjoying the heightened market activity. "Hopefully we'll enjoy this good environment for a while," he said. "We just don't know when it's going to stop."
Dimon mentioned an array of factors that could cause the strong activity and bull market to topple. "Large fiscal deficits, sticky inflation, elevated asset prices, rising interest rates and geopolitical conditions continue to shift under the surface," he said. He ended on a positive note, pointing out that "these forces may be manageable, but we remain prepared for a wide range of outcomes."
Each of these factors alone could have a major impact on the economy. The U.S. debt has reached $40.25 trillion and continues to rise, while many global regions are dealing with spiraling deficits. Inflation is still raging, aided in part by the resilient U.S. consumer, but it isn't likely to stay that way forever. Eventually, consumerism is likely to slow down, negatively affecting retailers and the overall economy.
The flip side of that is interest rates, which may soon be raised to counter inflation. Interest rates also slow the economy and specifically impact banks because fewer people look for loans when interest rates are high, both personally and commercially, and default rates rise.
$342.93+$7.40 (+2.21%)
NYSE · As of 11:27 AM ET 10/16/26
Rising asset prices are obvious as the S&P 500 gets closer to ending its fourth straight year with double-digit gains. That will come to an end at some point, and while slumping market activity wouldn't be good for JPMorgan Chase's trading segment, the bigger picture would be stalled economic activity as people's savings contract, at least in the short term.
Finally, geopolitical tensions continue in several regions, and specifically, the threat of rising oil prices remains. These are all reasons for investors to carefully consider the makeup of their portfolios right now and make sure they're well balanced to manage through any upcoming downturn.
Disney nabídne 66 zaměstnancům Character.AI odměny v hodnotě 60 milionů USD ročně a navíc vyčlení 30 milionů USD na retenční fond; během tří let tak na ně vynaloží 180 milionů USD.
Disney CEO Josh D'Amaro plans to hire employees from Character.AI, where new tech chief Karandeep Anand worked.
Taylor Hill/FilmMagic; Manaure Quintero / AFP via Getty Images
Disney is paying up for employees from an AI chatbot startup that filed for bankruptcy, shortly after trimming its own tech workforce.
The Mouse House plans to pay $60 million per year to 66 workers from Character.AI, according to a Chapter 11 filing on Tuesday from its parent company. In mid-September, Disney hired Character.AI CEO Karandeep Anand to be its first-ever company-wide tech chief. (The company hasn't yet disclosed how much it's paying Anand.)
These additions are part of Disney's AI strategy under CEO Josh D'Amaro, who's been investing in the media giant's tech platforms to help jumpstart a stagnant stock that's up less than 2% in the last 12 months and is down over 36% in the last five years.
Disney's decision to bring in these Character.AI staffers came two weeks after it laid off several hundred workers — including some tech employees. The late-September cuts were Disney's third major round of layoffs since D'Amaro took over in mid-March.
In addition to the $60 million in compensation, Disney is setting aside an additional $30 million for an "aggregate retention pool" to incentivize Character.AI employees to stay. The company expects to spend $180 million on "total compensation and retention" for these staffers in the next three years, the filing said.
Of the 66 Character.AI staffers who were offered jobs by Disney, 56 have already resigned from the AI startup, while the other 10 are waiting for the US government to update their work visas.
Entertainment lawyer Corey Martin of Granderson Des Rochers, who advises companies on media transactions, said he's not surprised by those pay figures since Character.AI's employees are its biggest asset.
"They're highly compensated employees. The numbers can be eye-popping, but it's not that unusual in this space," said Martin, who didn't work on the deal or with Disney.
Disney also agreed to pay $20 million for Character.AI's key assets, including some of its IP and tech. Other companies can submit competing bids for the assets by November 20. The entire process will be overseen by a bankruptcy court judge. Disney didn't respond to requests for comment for this story.
Character.AI filed for bankruptcy after facing lawsuits from families who alleged that their teenagers harmed themselves or committed suicide after using the company's custom AI chatbots. The AI startup and Google, one of its backers, settled several child safety lawsuits earlier this year.
Disney sent a cease-and-desist letter to Character.AI last fall, telling it not to create AI chatbots featuring its copyrighted characters without permission. Character.AI complied, removing chatbots with characters from Disney franchises like Star Wars and Marvel.
In its bankruptcy announcement, Character.AI said that it had been facing "significant legal, regulatory, and operational headwinds."
Anand told Disney employees in a memo last Friday that the Mouse House was "uniquely positioned to win" in a competitive media business that he said was "at an inflection point." The tech chief also said he enjoyed meeting his new colleagues and looked forward to working with them.
"What stands out most is the talent and care this team puts into its work, the craft Disney has perfected, and the strong foundation you've built," Anand said.
Read next
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
James Faris
You're currently following this author!
Click to unsubscribe from email alerts.
James Faris is a media correspondent in New York City.He covers the business of media & entertainment, specifically the streaming, TV, and AI strategies of Hollywood giants like Disney, Skydance (Paramount-WBD), and Netflix. He previously wrote about the stock market, the economy, and real estate.James joined Business Insider after graduating magna cum laude from James Madison University.Email James at [email protected] and follow him on LinkedIn.
Key Takeaways ExxonMobil's 13.73% debt-to-capitalization ratio provides financial flexibility amid oil and gas price swings.XOM's low debt exposure supports favorable borrowing, acquisitions and shareholder rewards during downturns.XOM shares gained 55.6% in a year, beating the industry's 54.6%, while its EV/EBITDA of 9.73X tops 6.31X. ExxonMobil Holdings Corporation (XOM - Free Report) , an integrated energy giant, generates the bulk of its earnings from upstream operations. With a strong presence in the prolific Permian Basin and offshore Guyana resources, its top and bottom lines are highly susceptible to fluctuations in oil and natural gas prices.
But investors should not worry much about this vulnerability. With a debt-to-capitalization of 13.73%, the energy giant has significantly lower exposure to debt capital. Thus, the company can rely on its strong balance sheet when oil and natural gas prices fall and the business scenario becomes unfavorable.
Also, with lower exposure to debt capital, XOM can secure additional debt on favorable terms during uncertain situations, allowing it to operate smoothly, pursue lucrative acquisitions and continue rewarding shareholders.
CVX & EOG Also Have Low Debt LoadChevron Corporation (CVX - Free Report) and EOG Resources Inc. (EOG - Free Report) , with robust balance sheets, can also sail through an unfavorable business environment on their strong financials. While CVX has a debt-to-capitalization of 15.94%, EOG’s debt-to-capitalization is 19.92%.
XOM’s Price Performance, Valuation & EstimatesShares of XOM have gained 55.6% over the past year compared with the industry’s 54.6% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, XOM trades at a trailing 12-month enterprise value to EBITDA (EV/EBITDA) of 9.73X. This is above the broader industry average of 6.31X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for XOM’s 2026 earnings has seen upward revisions over the past seven days.
Image Source: Zacks Investment Research
ExxonMobil currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Starbucks ve třetím čtvrtletí fiskálního roku 2026 zvýšil globální srovnatelné tržby o 7,9 %; provozní marže vzrostla na 14,4 % a zisk na akcii (EPS) o 70 % na 85 centů.
Key Takeaways Starbucks delivered 7.9% global comparable-store sales growth for the fourth consecutive quarter.Operating margin rose 430 basis points to 14.4%, while EPS increased 70% to 85 cents.Higher fiscal 2026 guidance supports recovery, but coffee costs and store closures remain key risks. Starbucks Corporation’s (SBUX - Free Report) shares have gained 15% year to date (“YTD”), outperforming the restaurant industry, which has declined 12% over the same period.
The stock's relative strength likely reflects improving sales momentum, progress in its Back to Starbucks turnaround strategy, recovering operating margins and an improved earnings outlook. The company's latest quarterly results showed stronger customer traffic and encouraging operating performance, prompting management to raise its fiscal 2026 earnings guidance.
In the same time frame, SBUX has outperformed other industry players like McDonald's Corporation (MCD - Free Report) , Chipotle Mexican Grill, Inc. (CMG - Free Report) and Yum! Brands, Inc. (YUM - Free Report) .
Price Performance
Image Source: Zacks Investment Research
Turnaround Strategy Is Gaining TractionStarbucks' Back to Starbucks strategy is centered on improving customer service, strengthening coffeehouse operations and restoring the brand's appeal. In the third quarter of fiscal 2026, the company delivered its fourth consecutive quarter of positive global comparable-store sales growth. Global comps increased 7.9%, reflecting improving customer traffic and stronger sales performance.
In the United States, comparable sales grew 7.9%, driven by a 4.2% increase in transactions and 3.6% growth in average ticket. Management attributed the progress to better store execution, improved staffing, menu innovation and stronger customer experiences. The limited contribution from pricing to average-ticket growth also suggests that traffic and product mix are playing important roles in the recovery.
The Green Apron Service model has helped Starbucks improve staffing, coaching and operating routines. Management reported that service-time targets were achieved across its ordering channels despite transaction growth. Food availability also approached 99%, approximately 10 percentage points higher than a year earlier. These improvements could support customer satisfaction, repeat visits and more consistent performance across coffeehouses.
Menu Innovation and Rewards Support Sales GrowthProduct innovation and marketing are providing additional growth opportunities. Starbucks' Refreshers platform delivered double-digit year-over-year revenue growth in the United States during the third quarter. Customizable beverages and new flavors have helped attract customers across different age groups and dayparts. Management also highlighted the growing opportunity to boost afternoon visits through beverages, food offerings and improved merchandising.
The revamped Starbucks Rewards program is another potential growth driver. Active 90-day membership in the United States reached 35.8 million, with engagement and average stored-value card reloads exceeding management's expectations. A stronger loyalty ecosystem could encourage more frequent visits and deepen customer relationships.
Starbucks is also improving its coffeehouse environment. The company surpassed 1,000 coffeehouse uplifts across North America ahead of its fiscal 2026 target and aims to complete at least 1,500 by year-end. Early results indicate higher transactions across store formats and ordering channels, while the upgrades cost approximately $150,000 per location on average. The relatively modest investment could support customer experience improvements without the disruption associated with extensive remodels.
Margin Recovery and Higher Guidance Offer SupportStarbucks' profitability is showing signs of recovery. Third-quarter consolidated operating margin expanded 430 basis points year over year to 14.4%, while earnings per share increased 70% to 85 cents. Sales leverage, cost savings and improved operating execution supported margin expansion.
The company remains on track with its $2 billion gross cost-savings plan through fiscal 2028. It also repaid approximately $1.8 billion of debt using part of the proceeds from its China transaction, lowering leverage to 2.9 times and strengthening financial flexibility.
Management raised its fiscal 2026 adjusted EPS guidance to $2.55-$2.65 and expects consolidated operating margin to exceed 11%. It anticipates U.S. comparable-store sales growth of more than 6% and global comps growth approaching 6% for the full fiscal year. These targets suggest continued improvement, although successful execution remains essential.
Costs, Store Closures and Execution Remain RisksDespite the encouraging trends, Starbucks faces several challenges. Third-quarter consolidated revenues declined approximately 1% year over year to $9.3 billion, largely because the transition of its China retail business to a joint venture changed how revenues are reported. Although the new structure is intended to create a more capital-efficient international business, the long-term economics remain subject to execution and market conditions.
Coffee costs continue to pressure margins, while persistent weakness in consumer sentiment could constrain discretionary spending. Starbucks also acknowledged that some North American coffeehouses may require closure because of weak performance, location issues or unattractive economics. Net new company-operated store growth in North America could remain modest through fiscal 2027.
Additionally, part of the third-quarter margin improvement benefited from reciprocal tariff refunds. Management indicated that the company had largely received the refunds to which it was entitled, making sustained improvement increasingly dependent on sales growth and operational efficiencies.
SBUX’s Estimate Revision TrendThe Zacks Consensus Estimate for SBUX's fiscal 2026 and 2027 EPS moved down in the past 30 days, indicating negative sentiment among analysts for its earnings. The company's earnings in fiscal 2026 and 2027 are likely to witness growth of 21.6% and 21.6% year over year, respectively.
Image Source: Zacks Investment Research
Taking a Look at Starbucks’ ValuationSBUX stock is trading below the industry. With a forward 12-month price/sales ratio of 2.83X, below its industry average. Meanwhile, other industry players like McDonald's, Chipotle Mexican Grill and Yum! Brands are trading at 5.95X, 2.75X and 4.6X, respectively.
P/S (F12M)
Image Source: Zacks Investment Research
Is SBUX Stock a Buy Now?Starbucks' improving traffic, product innovation, operating discipline and higher earnings outlook support the case for further recovery. However, cost pressures, potential store closures and the need to sustain comparable-sales growth could limit upside. With a Zacks Rank #3 (Hold), investors may prefer to monitor the company's progress in delivering profitable growth before taking a more aggressive position in the stock.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
KFC's decision to switch from Pepsi sodas to Coca-Cola (KO.N) at its US restaurants could raise questions about PepsiCo's (PEP.O) other longstanding food service partnerships, analysts said, even as they expect the financial hit to be manageable.
The loss of KFC comes as PepsiCo grapples with sluggish demand and higher costs in North America, where a recovery in growth and margins is taking longer than expected and has prompted the company to deepen cost cuts.
BofA analysts estimate the loss of the KFC account represents about $500 million in annual sales, equivalent to roughly a 3% hit to Pepsi Beverages North America's concentrate sales, while boosting Coca-Cola's North America sales by about 2.5%
Brokerage Jefferies says the bigger concern for PepsiCo is the "loss of brand interaction and public perception" rather than the immediate financial impact
"A longstanding Pepsi customer switching raises questions whether other accounts that have been historically off-limits are now up for grabs," Jefferies analysts said
"Investors see this (move) less as a seismic commercial loss for PepsiCo and more as the natural order of... (a brand) reasserting itself," says Richard Exon, founder and partner at Joint, an independent creative agency
Společnost American Express má za čtvrtletí končící v září 2026 vykázat EPS ve výši 4,47 USD, což by představovalo meziroční nárůst o 8 %, při výnosech 20,13 miliardy USD (+9,3 %).
Wall Street expects a year-over-year increase in earnings on higher revenues when American Express (AXP - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on October 23, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis credit card issuer and global payments company is expected to post quarterly earnings of $4.47 per share in its upcoming report, which represents a year-over-year change of +8%.
Revenues are expected to be $20.13 billion, up 9.3% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.55% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for American Express?For American Express, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.17%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that American Express will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that American Express would post earnings of $4.41 per share when it actually produced earnings of $4.53, delivering a surprise of +2.72%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
American Express doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsAmong the stocks in the Zacks Financial - Miscellaneous Services industry, Blackstone Inc. (BX - Free Report) , is soon expected to post earnings of $1.31 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -13.8%. This quarter's revenue is expected to be $3.36 billion, up 1.9% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Blackstone Inc. has been revised 0.7% down to the current level. Nevertheless, the company now has an Earnings ESP of -2.65%, reflecting a lower Most Accurate Estimate.
When combined with a Zacks Rank of #4 (Sell), this Earnings ESP makes it difficult to conclusively predict that Blackstone Inc. will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
This is a fair market value price provided by Massive. Learn more.
$844.06▼
$1,096.500.59%
47.62
$1,087.40
Despite soaring gas prices, high rates, and weak consumer sentiment, Americans continue to spend. While recent retail earnings have been mixed, reports from major banks have highlighted resilient consumer strength across both high- and low-income cohorts. Yes, consumers feel pinched by high prices (and slowing wage growth).
Still, spending continues, and cost-conscious consumers are the perfect clientele for warehouse-club retailers like Costco Wholesale Corp. NASDAQ: COST. COST stock hasn’t hit a new all-time high in nearly five months, but the fundamentals are accelerating just as the stock tests the 200-day moving average. Is Costco’s lackluster year finally about to pick up?
Get Costco Wholesale alerts:
Costco September Sales Snap 3 Months of DeclineCostco hit the market with a double blast of encouraging news in the last few weeks. First, the company reported its fiscal Q4 2026 results on Sept. 24, beating expectations on both the top and bottom lines with 6.7% year-over-year (YOY) comparable-sales growth after adjusting for currency and fuel. Earnings beat expectations even after removing 15 cents per share for one-time tariff refunds, and revenue of $95.72 billion beat expectations by more than $750 million. Membership metrics were also strong, with paid Executive members reaching 42.3 million and U.S./Canada renewal rates at 92.3%, up 10 basis points from fiscal Q3.
On Oct. 7, Costco reported its September sales brief, covering the five weeks ending Oct. 4. Adjusted comparable sales grew 7.6% YOY, the fastest pace since May’s 8% increase at the height of the Hormuz crisis. August adjusted comps came in at just 5.4%, so September marked a notable acceleration, even after removing 50 basis points for Labor Day tailwinds.
Canada was the lone sour spot with 4.9% adjusted comps, but Other International adjusted comps grew 7.7%. Gas is doing much of the heavy lifting in reported sales, with gasoline comps rising more than 30%. However, the adjusted figures exclude the effects of gasoline price changes and currency fluctuations, offering a clearer picture of underlying growth. Gas also drives foot traffic, and CFO Gary Millerchip said members who pump gas also visit stores more often.
Continued Sales Growth Could Reverse Analyst Price Target TrimmingCostco Wholesale MarketRank™ Stock Analysis4.418086500655 of 5 stars
88th Percentile
Moderate Buy
10.4% Upside
Healthy
Strong
1.01 Selling Shares
9.78%
See Full Analysis
Despite the double fiscal Q4 earnings beat on Sept. 24, analysts were in no hurry to raise their price targets. In fact, several firms lowered their price targets the day after the conference call, and Costco bear Bill Kirk at Roth Capital reiterated his Sell rating and $781 price target. Overall, MarketBeat tracks 32 analysts covering COST shares, with 23 Buys, eight Holds, and one Sell from Roth. The average price target is $1081.79, representing roughly 10% upside from recent trading levels.
Those price-target cuts came before Costco released its stronger September sales figures. A retailer trading at roughly 47 times earnings with slowing revenue growth is hard to keep boosting, even with solid revenue growth, so many analysts kept their rating at Buy while lowering their price targets. But now that September comps are above 7% again, the latest data suggest sales growth is accelerating, and elevated gas prices should continue to drive new memberships and more foot traffic. Analysts may wait for October sales data to confirm or deny the growth trend, but it wouldn’t be surprising to see some price-target reversals over the next few weeks if the stock continues to rally.
Daily Chart Shows COST Shares Approaching Key Technical LevelsCOST shares dipped below $900 in late September, the first time they fell below this key level since the first week of 2026. The stock is still up more than 13% year-to-date, but the drawdown since the May all-time high of approximately $1,095 was nearly 20% from peak to trough. After serving as strong support for the first half of the year, the 50-day moving average flipped to resistance during the decline, and the stock struggled to break above it until early October. But COST shares are now back above the 50-day and 200-day moving averages for the first time since May, and other technical signals are starting to turn positive.
The moving average convergence divergence (MACD) also shows an uptick in buying momentum, and the reversal began with a bullish MACD cross in late September. Now both the MACD and signal lines have crossed over the histogram, a common bullish signal that often triggers a broader rally. The stock is up more than 6% in the last month, which may not sound like a raucous rally, but it pushed the price over $980 for the first time in four months. Technical and fundamental signals are beginning to align, but we may still need one more month of sales data before we can say the COST rally is back in action.
Should You Invest $1,000 in Costco Wholesale Right Now?Before you consider Costco Wholesale, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Costco Wholesale wasn't on the list.
While Costco Wholesale currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Palantir Technologies Inc. (PLTR - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this company have returned +13.8%, compared to the Zacks S&P 500 composite's +1.4% change. During this period, the Zacks Internet - Software industry, which Palantir Technologies falls in, has gained 5.4%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, Palantir Technologies is expected to post earnings of $0.42 per share, indicating a change of +100% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $1.64 points to a change of +118.7% from the prior year. Over the last 30 days, this estimate has changed +2.4%.
For the next fiscal year, the consensus earnings estimate of $2.31 indicates a change of +41.1% from what Palantir Technologies is expected to report a year ago. Over the past month, the estimate has changed +0.1%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Palantir Technologies.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Palantir Technologies, the consensus sales estimate for the current quarter of $2.17 billion indicates a year-over-year change of +84%. For the current and next fiscal years, $8.23 billion and $11.77 billion estimates indicate +83.8% and +43.1% changes, respectively.
Last Reported Results and Surprise HistoryPalantir Technologies reported revenues of $1.94 billion in the last reported quarter, representing a year-over-year change of +92.8%. EPS of $0.41 for the same period compares with $0.16 a year ago.
Compared to the Zacks Consensus Estimate of $1.81 billion, the reported revenues represent a surprise of +7.16%. The EPS surprise was +17.14%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Palantir Technologies is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Palantir Technologies. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Palantir se při ceně kolem 198 USD obchoduje za zhruba 170násobek zisku za posledních 12 měsíců; ocenění na úrovni 120násobku zisku by odpovídalo asi 140 USD za akcii.
Shares of Palantir Technologies (PLTR -5.91%) ended Oct. 9 at $209.05, their highest close ever. They've dipped since. But at around $198 as I write, the stock still sits only about 5% under that high.
It's easy to see why investors keep paying up. The artificial intelligence (AI) data and analytics specialist grew its second-quarter revenue 93% year over year, and its profits rose even faster.
But at today's price, investors pay around 170 times earnings for it, going by what Palantir earned in the last year -- more than I'm willing to pay.
At what price, then, would the stock become a buy for me?
Image source: The Motley Fool.
Palantir's profits keep climbingHighlighting how fast the company is scaling, Palantir's second-quarter earnings per share more than tripled year over year, up from $0.13 to $0.41. Net income grew a bit faster still, hitting around $1.06 billion versus about $327 million in the year-ago quarter. Earlier quarters showed the same climb. Palantir's quarterly earnings per share rose from $0.18 in the third quarter of 2025 to $0.24 in the fourth quarter, then to $0.34 in the first quarter of 2026 before hitting $0.41 in the second.
Add those four quarters up, and Palantir earned $1.17 per share over the last year. That's almost four times the $0.30 per share it earned in the four quarters before.
I'll use that trailing $1.17 as my earnings figure, because it's what the company reported, not an estimate.
Of course, the quarter-to-quarter gains are shrinking. Earnings per share rose around 42% from the fourth quarter to the first quarter, but only about 21% from the first quarter to the second.
Even for a business growing so fast, paying about 170 times earnings of $1.17 a share is a lot for profits that have already been booked.
What did investors pay at the low?To choose a valuation multiple, I don't have to guess what a fast-growing software business might deserve. Palantir showed what investors were willing to pay for it just a few months ago.
On June 25, shares ended at around $107, the lowest closing price over the last 12 months. At that time, Palantir's trailing earnings per share came to $0.89, based on the four quarters through March. So, even near the bottom of a tough first half, investors paid around 120 times earnings.
That's still a rich price-to-earnings multiple. But it's one the market has already accepted for this business during a time when sentiment was weak -- and just weeks before Palantir posted 93% revenue growth for the second quarter.
Apply that 120 times earnings to Palantir's trailing earnings per share of $1.17, and you get around $140 a share, or about 29% under today's price.
The stock might not need to fallA 29% drop is one way to get there. The stock has fallen more than that recently, losing around 34% of its value in the first half of 2026.
But earnings might do the job instead. The quarter that drops out of the trailing total next is the third quarter of 2025, when Palantir earned $0.18 a share. If quarterly earnings per share just stayed at the second quarter's $0.41 for three more reports, trailing earnings would climb to about $1.64. At 120 times earnings, that's about $197 -- right around where the stock trades today. If earnings keep growing instead, it might get there earlier.
PLTR Palantir Technologies$188.66-$11.84 (-5.91%)
NASDAQ · As of 11:21 AM ET 10/16/26
Management's forecast suggests profits aren't stalling, either. For the third quarter, Palantir guided for non-GAAP (adjusted) operating income of around $1.29 billion. That would be around 8% over the second quarter's adjusted number and more than twice the year-ago quarter's.
Of course, nothing guarantees earnings stay at that level. Quarter-to-quarter earnings growth is already cooling. And Palantir booked hardly any income tax expense in the second quarter -- around $15 million on about $1.08 billion in pre-tax income. If its tax rate climbs, earnings per share could grow slower than operating profit does.
In the end, Palantir is executing about as well as any software company I track. The catch is that today's price arguably assumes it keeps this up for years.
So, I'd consider buying Palantir stock at around $140 per share, or about 120 times its earnings for the last four quarters. If these earnings keep rising, that price should rise with them. At around $198 today, the stock still sits far above it.
Palantir pro rok 2026 očekává upravené volné cash flow ve výši 4,5–4,7 mld. USD, zatímco generální ředitel Alex Karp cílí během dvou let na 15–18 mld. USD.
This is a fair market value price provided by Massive. Learn more.
$106.37▼
$212.94160.35
$201.61
Are retail investors bailing on Palantir Technologies NASDAQ: PLTR? At least one group of shareholders was selling. In its August 2026 Schwab Trading Activity Index report, Charles Schwab reported that PLTR was one of several high-beta technology stocks that its clients net sold.
The top-of-mind question is why? Schwab cites profit-taking and rotation within the tech sector as two reasons for the selling. That holds up, given that names like SpaceX NASDAQ: SPCX, Micron Technology NASDAQ: MU, and Intel Corp. NASDAQ: INTC were among those that saw net buying during the month.
Get Palantir Technologies alerts:
PLTR has gained more than 50% over the past three months. That means somebody has to be doing the buying. In this case, it appears that institutions are finally sending a signal that it's time to dive in.
Wall Street Is Playing Catch-UpOver the past three months, the consensus price target from the analysts tracked by MarketBeat has risen from $190.85 to $201.61, compared with $194.04 a month ago. That's an increase of nearly 6%, but PLTR's share price has climbed much faster. With shares trading near $200, the consensus target now implies little additional upside.
Current Price$195.01High Forecast$265.00Average Forecast$201.61Low Forecast$80.00Palantir Technologies Stock Forecast Details
Here's where the story gets better. Institutional ownership in PLTR is still around 45%. That compares with roughly 80% for Micron and about 64% for Intel, two of the stocks Schwab clients were buying. That gap leaves plenty of room for fund managers to build positions, although it doesn't guarantee they will.
Retail investors drove a strong move in Palantir. But it's institutional money that will likely be the catalyst for the next leg higher. MarketBeat's institutional ownership data shows more institutional buyers than sellers over the past year, while recent analyst activity suggests improving sentiment.
In October alone, Goldman Sachs upgraded PLTR from Neutral to Buy with a $230 price target. Raymond James upgraded the stock from a Hold to a Moderate Buy. Barclays initiated coverage with an Overweight rating and a $265 price target. And Robert W. Baird also set a fresh price target of $250 on PLTR.
A $250 price target would imply roughly 25% upside from recent trading levels. While that is well above the current consensus, it reflects the more bullish outlook emerging among some Wall Street analysts.
Karp's Ambitious Free Cash Flow ForecastThe growing optimism follows the company's blowout Q2 2026 earnings report in August. The headline numbers comfortably beat expectations; Palantir is showing strong growth in both the commercial and government sides of its business.
But one of the most ambitious projections came earlier, during a July 1 CNBC interview. That's when CEO Alex Karp said Palantir could generate $15 billion to $18 billion in free cash flow within two years.
It's important to put that in perspective. For the full year 2026, the company is forecasting adjusted FCF between $4.5 billion and $4.7 billion. Achieving Karp's bullish forecast will require FCF to grow by roughly 80% to 100% annually.
Before dismissing that kind of growth, remember that Palantir delivered adjusted FCF growth of 115% in the second quarter. Plus, Karp has a track record of delivering on forecasts that skeptics dismissed as talking his book.
Sovereign AI Gives Institutions a Story to UnderwriteThe company is also getting a boost as the concept of sovereign AI has become front-and-center in the AI trade. The real story here goes back to institutional interest. The issue of sovereign AI has been an "aha moment" that has crystallized Palantir's one-of-one role in the AI stack.
Sovereign AI refers to nations building AI capabilities they control, from the data to the models to the software that runs on top of them. For governments, that’s a matter of national security. Few software companies have Palantir’s decades of experience operating inside classified environments. Recent partnerships, including a sovereign AI push with edge-computing company Armada, reinforce that position.
For institutional investors, that matters. It’s easier to justify a premium multiple for a company with a defensible moat than for a stock riding an AI narrative.
What the Chart Says Ahead of EarningsThe Oct. 14 session was a reminder that the handoff won’t be smooth. PLTR fell about 4% after briefly trading above $209, giving back its break above the November 2025 record high near $207.50. But the selling came on relatively light volume, and buyers stepped in right at the $200 level.
The 50-day simple moving average, now around $181, is rising steeply but sits roughly 10% below the current price. That shows how extended the move has become. The MACD remains above its signal line, but the histogram has started to narrow, which suggests momentum is cooling rather than reversing.
Palantir is expected to report Q3 results in early November. If institutions are truly stepping in, dips toward $200, or even the 50-day average, should attract buyers rather than trigger an exodus. Retail investors who sold in August may have locked in solid gains. The question is whether they left the next leg of the move on the table for Wall Street.
Should You Invest $1,000 in Palantir Technologies Right Now?Before you consider Palantir Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Palantir Technologies wasn't on the list.
While Palantir Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Micron očekává ve stávajícím čtvrtletí zisk na akcii ve výši 38,20 USD, což představuje meziroční nárůst o 699,2 %; konsenzuální odhad za posledních 30 dní vzrostl o 9,8 %.
Micron (MU - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this chipmaker have returned -4.7%, compared to the Zacks S&P 500 composite's +1.4% change. During this period, the Zacks Computer - Integrated Systems industry, which Micron falls in, has gained 2.9%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Micron is expected to post earnings of $38.20 per share for the current quarter, representing a year-over-year change of +699.2%. Over the last 30 days, the Zacks Consensus Estimate has changed +9.8%.
For the current fiscal year, the consensus earnings estimate of $177.73 points to a change of +135.3% from the prior year. Over the last 30 days, this estimate has changed +12%.
For the next fiscal year, the consensus earnings estimate of $211.82 indicates a change of +19.2% from what Micron is expected to report a year ago. Over the past month, the estimate has changed +11.9%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for Micron.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Micron, the consensus sales estimate for the current quarter of $61.76 billion indicates a year-over-year change of +352.7%. For the current and next fiscal years, $275.11 billion and $332.98 billion estimates indicate +106.6% and +21% changes, respectively.
Last Reported Results and Surprise HistoryMicron reported revenues of $54.23 billion in the last reported quarter, representing a year-over-year change of +379.3%. EPS of $33.42 for the same period compares with $3.03 a year ago.
Compared to the Zacks Consensus Estimate of $51 billion, the reported revenues represent a surprise of +6.32%. The EPS surprise was +5.73%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Micron is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Micron. However, its Zacks Rank #1 does suggest that it may outperform the broader market in the near term.
Analytici očekávají, že Thermo Fisher ve 3. čtvrtletí dosáhne zisku 6,40 USD na akcii a tržeb ve výši 11,92 mld. USD, což by představovalo meziroční nárůst o 10,5 %, respektive o 7,2 %.
Wall Street analysts expect Thermo Fisher Scientific (TMO - Free Report) to post quarterly earnings of $6.40 per share in its upcoming report, which indicates a year-over-year increase of 10.5%. Revenues are expected to be $11.92 billion, up 7.2% from the year-ago quarter.
Over the last 30 days, there has been an upward revision of 0.2% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some Thermo Fisher metrics that are commonly tracked and projected by analysts on Wall Street.
Analysts' assessment points toward 'Revenues- Laboratory Products and Biopharma Services' reaching $6.56 billion. The estimate points to a change of +9.9% from the year-ago quarter.
The consensus estimate for 'Revenues- Specialty Diagnostics' stands at $1.14 billion. The estimate points to a change of -3% from the year-ago quarter.
Analysts forecast 'Revenues- Life Sciences Solutions' to reach $2.85 billion. The estimate indicates a change of +10.3% from the prior-year quarter.
Based on the collective assessment of analysts, 'Revenues- Analytical Instruments' should arrive at $1.95 billion. The estimate indicates a change of +2.8% from the prior-year quarter.
The consensus among analysts is that 'Revenue Growth - Organic' will reach 4.2%. Compared to the current estimate, the company reported 3.0% in the same quarter of the previous year.
View all Key Company Metrics for Thermo Fisher here>>>
Thermo Fisher shares have witnessed a change of +5.8% in the past month, in contrast to the Zacks S&P 500 composite's +2.4% move. With a Zacks Rank #2 (Buy), TMO is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Analytici očekávají, že Danaher ve čtvrtletí vykáže zisk 1,92 USD na akcii a tržby ve výši 6,55 miliardy USD, což představuje meziroční nárůst o 1,6 %, respektive o 8,2 %.
Analysts on Wall Street project that Danaher (DHR - Free Report) will announce quarterly earnings of $1.92 per share in its forthcoming report, representing an increase of 1.6% year over year. Revenues are projected to reach $6.55 billion, increasing 8.2% from the same quarter last year.
Over the past 30 days, the consensus EPS estimate for the quarter has remained unchanged. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Danaher metrics that are routinely monitored and predicted by Wall Street analysts.
The consensus among analysts is that 'Total Sales- Diagnostics' will reach $2.83 billion. The estimate points to a change of +14.9% from the year-ago quarter.
Analysts' assessment points toward 'Total Sales- Life Sciences' reaching $1.84 billion. The estimate indicates a change of +2.9% from the prior-year quarter.
Analysts forecast 'Total Sales- Biotechnology' to reach $1.87 billion. The estimate indicates a year-over-year change of +4%.
According to the collective judgment of analysts, 'Total Growth - Organic sales (Core)' should come in at 2.5%. Compared to the present estimate, the company reported 3.0% in the same quarter last year.
Analysts predict that the 'Operating profit- Life Sciences' will reach $255.41 million. The estimate compares to the year-ago value of $222.00 million.
Analysts expect 'Operating profit- Biotechnology' to come in at $483.60 million. The estimate is in contrast to the year-ago figure of $352.00 million.
The average prediction of analysts places 'Operating profit- Diagnostics' at $704.10 million. The estimate is in contrast to the year-ago figure of $665.00 million.
View all Key Company Metrics for Danaher here>>>
Over the past month, Danaher shares have recorded returns of +8.9% versus the Zacks S&P 500 composite's +2.4% change. Based on its Zacks Rank #2 (Buy), DHR will likely outperform the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Analytici očekávají, že Texas Instruments vykáže za čtvrtletí zisk na akcii (EPS) ve výši 2,38 USD a tržby ve výši 5,91 miliardy USD, což představuje meziroční nárůst o 60,8 %, respektive o 24,7 %.
Analysts on Wall Street project that Texas Instruments (TXN - Free Report) will announce quarterly earnings of $2.38 per share in its forthcoming report, representing an increase of 60.8% year over year. Revenues are projected to reach $5.91 billion, increasing 24.7% from the same quarter last year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.1% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Given this perspective, it's time to examine the average forecasts of specific Texas Instruments metrics that are routinely monitored and predicted by Wall Street analysts.
Analysts expect 'Revenue- Analog' to come in at $4.76 billion. The estimate indicates a year-over-year change of +27.7%.
The consensus estimate for 'Revenue- Embedded Processing' stands at $836.25 million. The estimate points to a change of +18% from the year-ago quarter.
Analysts predict that the 'Revenue- Other' will reach $315.39 million. The estimate suggests a change of +3.8% year over year.
Analysts' assessment points toward 'Operating Profit- Analog' reaching $2.18 billion. Compared to the present estimate, the company reported $1.49 billion in the same quarter last year.
Analysts forecast 'Operating Profit- Embedded Processing' to reach $181.08 million. Compared to the present estimate, the company reported $108.00 million in the same quarter last year.
View all Key Company Metrics for Texas Instruments here>>>
Texas Instruments shares have witnessed a change of +8.1% in the past month, in contrast to the Zacks S&P 500 composite's +2.4% move. With a Zacks Rank #2 (Buy), TXN is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Modern warfare demands a delicate balancing act. Global powers are actively modernizing legacy nuclear deterrence systems while simultaneously scrambling to counter cheap, asymmetric drone swarms. Capturing defense sector spending on both ends of this spectrum requires an integrated manufacturing footprint.
RTX Today
$191.30 +4.36 (+2.33%)
As of 11:36 AM Eastern
This is a fair market value price provided by Massive. Learn more.
$156.10▼
$226.881.53%
33.71
$226.75
Raytheon, a business unit of RTX Corporation NYSE: RTX, recently secured an $8 billion sole-source nuclear command-and-control modernization award alongside its first international counter-drone contract. These dual wins position RTX at the center of the world's most critical defense priorities.
Get RTX alerts:
With revenue pathways locked through approximately 2036, urgent munitions restocking driving production floors, and high-margin export streams launching in the Middle East, defense contract momentum is transitioning into sustained cash-flow expansion. As military budgets adapt to overlapping global conflicts, the broader aerospace sector is re-rating. A recent pullback in RTX's stock price offers a disciplined entry point into a defense heavyweight possessing unmatched multi-decade visibility.
Arming Two Fronts: Strategic and TacticalAerospace investors might feel they have to choose between high-end legacy prime contractors and nimble tactical technology firms. Raytheon breaks that assumption. The defense giant just landed an $8 billion sole-source indefinite-delivery/indefinite-quantity contract to modernize the U.S. Air Force's Nuclear Command, Control, and Communications terminals. Running through late 2036, this agreement ensures Raytheon will build and sustain the communications architecture connecting the nation's strategic nuclear triad for the next decade.
Simultaneously, Raytheon announced a $729 million award to deliver the Low, Slow, Small Unmanned Aircraft Integrated Defeat System to the U.S. Army, Qatar, and Jordan. This package integrates the Ku-band Radio Frequency Sensor radar with the Coyote drone interceptor. What makes this particular award notable is its reach. It marks the first international export of the Coyote and KuRFS platforms.
This is the modern defense barbell in action. Defense budgets are currently allocating heavy capital to deter existential threats while also funding immediate solutions to daily drone skirmishes. Capturing both ends of this spending spectrum creates a resilient revenue base for Raytheon.
Locking in a Decade of Defense RevenueSecuring a 10-year sole-source agreement for nuclear communications provides a predictable floor for long-term revenue. While the initial funded obligation for the contract sits at around $800,000, the sole-source structure effectively locks in future congressional appropriations. Raytheon does not have to fight for this specific budget allocation every year, as the long-term acquisition pathway is already cemented into the military supply chain.
On the tactical side, the roughly $729 million counter-drone contract acts as a gateway to high-margin recurring revenue. Foreign Military Sales traditionally carry more favorable margins than domestic procurement.
By exporting the KuRFS and Coyote systems to allied nations like Qatar and Jordan, Raytheon establishes a global footprint for its tactical hardware. Air defense is not a one-time purchase. Once a nation installs the radar systems and launchers, it must continually restock the interceptor missiles to maintain readiness.
This creates a consumable razor-and-blade business model where early international agreements yield decades of profitable restocking orders. As global demand for drone mitigation rises, Raytheon is positioning itself as the primary supplier for allied nations.
Restocking the Global ArsenalThe Pentagon is aggressively replenishing inventory depleted by ongoing global operations. The Department of Defense recently awarded Raytheon a $6.3 billion multi-year contract for SM-3 Block IB ballistic missile interceptors. When layered on top of the approximate $24.4 billion Standard Missile-6 production enterprise, the sheer volume of interceptor demand becomes clear. Active combat theaters are consuming munitions faster than supply chains can produce them, converting authorized defense budgets directly into near-term backlog expansion.
Raytheon is also demonstrating a level of operational agility rarely seen among legacy defense primes. The business completed three successful test flights for its upgraded Coyote Block 2C+RM platform in just 15 months.
This rapid development cycle contrasts sharply with the slower, single-digit organic growth profiles currently observed at peers like Lockheed Martin Corporation NYSE: LMT and General Dynamics Corporation NYSE: GD. Raytheon's ability to innovate quickly and scale production lines translates directly into margin capture. When the military needs immediate solutions for active combat zones, contractors that can bypass years of bureaucratic testing phases win the lucrative replenishment orders.
Cash Flow Shields Against Market ShocksFrom a fundamental perspective, defense contractors often trade at a premium due to their insulated revenue streams. RTX currently trades at a trailing price-to-earnings ratio near 33x, which might appear elevated at first glance. Looking ahead to projected earnings, the forward multiple compresses to about 26x. This re-rating is supported by Wall Street consensus estimates lifting fiscal year 2027 earnings projections toward $7.87 per share.
Raytheon generates healthy operating cash flow of around $9.58 per share, easily covering its dividend yield of approximately 1.6%. For investors wary of macroeconomic headwinds, the stock offers a remarkably low beta of 0.31, indicating minimal correlation with broader market swings.
Beyond government contracts, defense is only one side of the ledger. Raytheon benefits from an accelerating commercial aerospace aftermarket. The Pratt & Whitney and Collins Aerospace divisions are riding a wave of commercial maintenance, repair, and overhaul demand, with analysts projecting roughly 11.6% growth in this segment through 2027.
Airlines are keeping older planes in service longer because new aircraft deliveries are delayed across the manufacturing industry, directly benefiting engine makers and parts suppliers. This recurring commercial maintenance revenue provides a cash cushion that buffers against any temporary political friction in defense spending.
Securing a Position in the Aerospace ShieldWith third-quarter earnings approaching, the market will look for evidence that recent contract momentum is flowing into operating margins. During the second quarter, Raytheon beat expectations, posting earnings of $1.89 per share against a $1.66 estimate on approximately $24.71 billion in revenue.
Current Price$188.74High Forecast$265.00Average Forecast$226.75Low Forecast$195.00RTX Stock Forecast Details
Shares are trading around $186, down about 18% from their 52-week peak near $226.88. This consolidation comes despite average analyst price targets around $227, implying healthy upside over the coming year.
The recent string of multi-billion-dollar awards confirms that global demand for both strategic deterrence and tactical air defense is accelerating.
With a fortified balance sheet, expanding foreign military sales, and a 10-year runway in nuclear communications, the fundamental thesis remains intact. Cautious investors might consider evaluating positions during this pullback, securing a defensive asset with a clear trajectory for multi-year expansion.
Should You Invest $1,000 in RTX Right Now?Before you consider RTX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RTX wasn't on the list.
While RTX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Morgan Stanley ve 3. čtvrtletí překonala očekávání, ale její akcie 14. října klesly o 2,7 % kvůli závislosti výsledků na výnosech z obchodování. Divize správy majetku dosáhla rekordních tržeb kolem 9 mld. USD.
In what is shaping up to be a big week of bank earnings, Morgan Stanley NYSE: MS delivered its Q3 report on Oct. 14, comfortably beating analyst expectations on the headline numbers. However, as with Citigroup Inc. NYSE: C the day before, the market sold off the stock.
Morgan Stanley Today
MS
Morgan Stanley
$183.12 +1.02 (+0.56%)
As of 11:36 AM Eastern
This is a fair market value price provided by Massive. Learn more.
$152.80▼
$232.252.51%
14.54
$214.71
Morgan Stanley shares fell 2.7% in the Oct. 14 session, leaving them at around $180, where they had begun the year after a 20% slide from July’s high. For a headline beat, that is a chilly reception, and it points to a familiar tension in how the major banks are being judged this quarter. Like many of its peers in recent days, Morgan Stanley’s results looked strong on the surface, but the underlying fundamentals gave investors reason to pause.
Get Morgan Stanley alerts:
So just how good was the quarter beneath the headline, and what do the results say about where the stock goes next?
The Wealth Engine Did Its JobThe best of the quarter came from the part of Morgan Stanley that is supposed to be boring, and that may be the most reassuring thing in the whole report. Its wealth management arm pulled in record revenue of roughly $9 billion while gathering more than $230 billion of net new client money, much of it the fee-based flows that keep paying year after year.
This is the heart of the bull case as we head into the final few months of the year. For a long time now, Morgan Stanley has been reshaping itself from being a cyclical trading house into a fee-driven wealth manager, and a quarter like this shows the strategy working. The more of its earnings that come from steady advisory and management fees, the less the wider business should be exposed to the market’s changing moods.
A Beat That Leaned on TradingLook closer, though, and the quarter was less tidy than the headline, or solid wealth management results, suggested. A big slice of the strength came from equities trading, a notoriously fickle business that happened to boom last quarter, while fixed-income trading slipped and investment-banking fees barely grew. While it feels good when it lands like this, the snag is that a trading boom is the least reliable kind of beat there is, and can’t be trusted to repeat itself.
There were softer edges elsewhere, too. Profitability eased back from an unusually strong prior quarter, the firm tucked away more against potential loan losses, and a larger share of revenue went toward employee compensation. None of it was alarming, but together it made the beat look more cyclical, and less durable, than the top line implied.
That’s why a seemingly strong quarter still sent the shares lower. The market has no doubt that Morgan Stanley can beat when trading conditions are good; it just wants more proof that the wealth business can carry the load when trading inevitably cools.
How It Stacks Up Against the PackIt will be some comfort, but perhaps not much, to investors that Morgan Stanley was far from alone in being sold after earnings. It’s been a consistent theme, with equities desks and dealmaking running hot, fixed income running cold, ordinary lending holding steady, and the reserves that banks keep against bad loans edging up. And shares are selling off regardless of how strongly results beat expectations.
For all the fuss, however, the longer-term case hasn’t changed, and may even have strengthened. A record wealth management quarter and a flood of new client assets are exactly the kind of results the long-term bulls will have wanted to see, and with the stock back to flat for the year, much of the summer’s froth has likely been shaken out.
The Upside Potential Is Still StrongMorgan Stanley Stock Forecast Today12-Month Stock Price Forecast:
$214.71
17.49% Upside
Moderate Buy
Based on 27 Analyst Ratings
Current Price$182.75High Forecast$262.00Average Forecast$214.71Low Forecast$190.00Morgan Stanley Stock Forecast Details
At the same time, the stock still holds a Moderate Buy consensus, and even the cautious voices see upside: TD Cowen reiterated a Hold last week with a $210 target, while UBS stuck with a Buy and a punchier $236.
Both targets sit comfortably above the $180 where Morgan Stanley shares traded after their post-earnings drop, and suggest the market may have been too quick to mark down a quarter that was, underneath it all, rather good.
The risk, as ever, is that the trading tailwind fades before the rest of the business can fully pick up the slack, and the stock isn’t yet priced as if that will happen. But for investors willing to look through near-term uncertainty, Morgan Stanley just reminded them why its long-term story is worth backing.
Should You Invest $1,000 in Morgan Stanley Right Now?Before you consider Morgan Stanley, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.
While Morgan Stanley currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Accenture bude zaměstnancům od 1. října proplácet za Claude jen 29 USD měsíčně; vyšší náklady budou muset účtovat projektům, přestože někteří dosud platili 500 až 1 000 USD.
Accenture sells AI transformation to thousands of clients while quietly telling its own employees they get a fraction of what some were already spending. The internal memo reveals a tension at the heart of every major consulting firm racing to…
An Accenture (NYSE:ACN | ACN Price Prediction) consultant building an AI solution for several clients said Claude Code usage ran between $500 and $1,000 a month. Starting October 1, the company will centrally fund $29 per person.
Accenture told many employees in an internal memo, reported on October 15, 2026, that it will pay only that fixed monthly amount toward Claude, the AI model built by privately held Anthropic. Anything above it must be charged to a project.
Accenture sells AI transformation to roughly 9,000 clients. Internally, it now limits spending on the same tools.
Shares rose 4.63% to $224.92 on October 15 during a broad software rally unrelated to the memo, yet they remain well below the 52-week high of $291.09.
What Accenture’s Claude Memo Actually Commits To The memo, titled “Claude Enterprise Users: Important Updates to Licensing and Usage Costs,” states that “all costs are consumption-based.” Usage above the allowance goes to a Work Breakdown Structure (WBS), Accenture’s billing code for a project or team.
Heavy use remains possible, but it now needs a budget owner. Premium plans include $250 of weekly token usage, although many employees are not on Premium.
Access is conditional. The memo says, “Providing a WBS and obtaining a license does not guarantee indefinite or ongoing access to Claude,” and one employee lost access entirely.
Accenture did not publish the memo or say how many employees are affected. A spokesperson said, “Our approach today is to provide the right tool for the right work.”
Consumption Billing Shows What Coding AI Really Costs The $29 cap targets a consumer subscription price point. Agentic coding tools, which carry out complex tasks on their own, consume far more tokens, the units AI models bill by.
One employee said usage topped $500 a month for months, and some spent as much as $1,000. Per-seat budgets are likely to fall short once work shifts to autonomous coding.
CEO Julie Sweet said on the October 1 earnings call that falling token costs will “enable companies to use AI in more places and at scale.” The memo suggests that prices likely have further to fall before agentic coding becomes cheap enough to fund on a per-seat basis.
Why a Consultant Rations Its Own AI Accenture earns its margin on labor across roughly 814,000 employees. Unlimited token spending on that base is a cost that grows without a matching revenue line.
Charging overruns to a WBS ties AI spending to client work. Fixed-price work is over 65% of bookings, so AI costs on those contracts land on Accenture unless they were priced in.
Management guided to a 15.9% to 16.1% operating margin for fiscal 2027, which leaves little room for unmanaged expense.
Limits of a Single Secondhand Memo This is one policy, reported indirectly. Total spending, affected headcount, and whether other AI tools face similar limits remain unknown.
Accenture keeps expanding in AI, with nearly 110,000 AI and data professionals. Sweet also called the Anthropic relationship non-exclusive. For AI vendors, tight limits at the largest IT services firms could slow enterprise spending, although targeted use on proven work may last longer.
What Cost Discipline Means for Accenture’s Fiscal 2027 Outlook The memo shows cost discipline that supports fiscal 2027 guidance for GAAP EPS of $14.39 to $14.81.
The gap from the 52-week high, with market value at $134.05 billion, reflects fears that AI will reduce IT services billing. A record 141 quarterly bookings of $100 million or more argue demand is holding.
The thesis fails if management says at the next earnings report that AI tool costs are pressuring margins, or if first-quarter revenue lands below the $18.95 billion low end of guidance.
Contact [email protected] for any questions or corrections.
Key Takeaways Accenture spent $4.9 billion on 17 acquisitions in fiscal 2026 and plans $8 billion in fiscal 2027.About $3 billion is tied to Cyber OT acquisitions, with another $5 billion planned for fiscal 2027 deals.Accenture expects acquisitions to contribute 2-2.5 percentage points to fiscal 2027 growth.
Accenture plc (ACN - Free Report) is stepping up its acquisition strategy, with approximately $8 billion in planned investments for fiscal 2027. The aggressive spending underscores its efforts to strengthen industry expertise, expand into emerging markets and accelerate growth. However, integration challenges could complicate the company's expansion ambitions.
ACN's $8B Acquisition PipelineAccenture invested $4.9 billion across 17 acquisitions in fiscal 2026 compared with $1.5 billion across 23 transactions in fiscal 2025. The substantial increase in spending despite fewer transactions highlights its growing appetite for larger acquisitions.
For fiscal 2027, approximately $3 billion of the projected $8 billion relates to Cyber Operational Technology (OT) acquisitions, including Dragos. These transactions shifted from the fourth quarter of fiscal 2026 to the first quarter of fiscal 2027 due to regulatory timing.
Management expects to deploy another approximately $5 billion toward acquisitions during fiscal 2027.
Accenture's Inorganic Growth ExpectationsAccenture's inorganic contribution to growth was approximately 1.5 percentage points in fiscal 2026, down from 3 percentage points in fiscal 2025.
For fiscal 2027, management anticipates inorganic growth of about 2-2.5 percentage points, highlighting the potential benefits of its expanding acquisition portfolio.
The strategy centers on scaling high-growth businesses, strengthening industry-specific capabilities and entering new growth markets. Cybersecurity-related investments could further enhance its enterprise technology offerings.
What Could Limit ACN's Acquisition Upside?Despite promising opportunities, substantial acquisition spending carries integration and execution risks. Delays in closing transactions, higher integration costs and weaker-than-expected synergies could weigh on returns.
Accenture's ability to convert its expanding portfolio into sustained revenue growth and stronger profitability will ultimately determine whether its acquisition strategy translates into meaningful shareholder value.
How Do IBM and Cognizant Compare?International Business Machines Corporation (IBM - Free Report) and Cognizant Technology Solutions Corporation (CTSH - Free Report) are two U.S.-listed competitors pursuing growth through technology investments and acquisitions.
IBM continues to strengthen its hybrid cloud, artificial intelligence, and consulting capabilities through strategic transactions. These investments help IBM address evolving enterprise technology requirements, although integration complexities and competitive pressures remain concerns. IBM's diversified portfolio provides additional growth opportunities.
Cognizant is expanding its digital transformation capabilities through investments in artificial intelligence, cloud computing and industry-specific solutions. Strategic acquisitions help Cognizant broaden its service portfolio and deepen client relationships. However, Cognizant faces intense competition, pricing pressure and uncertainty surrounding discretionary technology spending.
ACN’s Price Performance, Valuation & EstimatesThe stock has gained 56% over the past three months compared with the industry’s 11% rise.
Image Source: Zacks Investment Research
From a valuation standpoint, ACN trades at a forward price-to-earnings ratio of 14.50X, below the industry average of 18.46X. It carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for ACN’s fiscal 2027 earnings has increased slightly over the past 60 days.
ACN currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Accenture očekává ve fiskálních letech 2027 a 2028 růst tržeb ve středních jednotkách procent, ve fiskálním roce 2029 pak ve středních až vyšších jednotkách procent, a to díky AI.
A couple of analysts raised the price target for Accenture plc (NYSE:ACN) after the company outlined a multi-year growth plan at its Investor Day on Wednesday.
TD Cowen analyst Bryan C. Bergin raised his price target from $193 to $201 while keeping a Hold rating. Susquehanna analyst James Friedman raised his price target from $210 to $230 while maintaining a Neutral rating. Accenture Sets Multi-Year Growth and Shareholder Return TargetsAt its Investor Day, Accenture outlined a growth strategy focused on mid-single-digit revenue growth, continued margin expansion, strong free cash flow and substantial shareholder returns through dividends and share buybacks.
Accenture expects mid-single-digit revenue growth in local currency in fiscal 2027 and fiscal 2028, accelerating to mid- to high-single-digit growth in fiscal 2029.
The company targets annual operating margin expansion of 10–30 basis points throughout fiscal 2027–2029.
Accenture expects free cash flow to net income of at least 1.1x in fiscal 2027 and fiscal 2028, rising to 1.2x–1.3x in fiscal 2029. It also targets at least $9.5 billion in free cash flow in fiscal 29.
The company plans to return cash to shareholders through dividends and buybacks.
It targets a dividend payout ratio in the mid-40% range of prior-year net income in fiscal 2027, increasing to the high-40% range in fiscal 2028 and fiscal 2029.
Accenture also targets 5% dividend-per-share growth and $5.5 billion in share repurchases in fiscal 2027.
The company expects repurchases to exceed share issuances in both fiscal 2027 and fiscal 2028.
TD Cowen: AI Growth Potential Faces Execution HurdlesTD Cowen analyst Bryan C. Bergin said Accenture presented a clear growth strategy as enterprise AI adoption expands, highlighting opportunities in capital projects, data and AI services, mid-market clients and operational technology cybersecurity.
However, investors remain focused on whether Accenture can accelerate growth despite AI-driven efficiencies. Execution in fiscal 2027 will be crucial to validating the company’s growth outlook.
Accenture’s multi-year growth framework draws on experience across more than 18,000 AI projects and an increase in Data and AI engagements worth more than $50 million.
Bergin added that the fiscal 2027–2029 outlook also depends on improving macroeconomic conditions and sustained mid-single-digit growth in Accenture’s core business, which accounts for 94% of revenue. Ongoing modernization in ERP, cloud, cybersecurity and data is expected to provide further growth opportunities.
Susquehanna Expects AI to Accelerate Revenue GrowthSusquehanna analyst James Friedman said Accenture’s past technology shifts, including offshoring, cloud and digital adoption, reduced costs and replaced some IT services but also stimulated demand for business services, supporting the company’s growth.
Friedman expects AI to follow a similar pattern, with revenue growth accelerating in fiscal 2029.
The analyst projects first-quarter fiscal 2027 revenue growth of 2.5% to $19.2 billion and full-year fiscal 2027 revenue growth of 4% to $77.2 billion. He forecasts EPS of $3.97 for the first quarter and $14.62 for the full year.
Revenue is expected to increase 5.7% to $81.6 billion in fiscal 2028 and 7% to $87.3 billion in fiscal 2029, with EPS reaching $16.00 and $17.78, respectively.
Operating margins are projected to expand from 16% in fiscal 2027 to 16.2% in fiscal 2028 and 16.4% in fiscal 2029.
Read Next
ACN Stock Price Activity: Accenture shares were down 0.05%% at $224.90 at publication on Friday.
Key Takeaways FIS stock is down nearly 48% from its 52-week high, but stronger cash flow and margins offer recovery hope.FIS' second-quarter free cash flow surged 220% to $525 million, supporting debt reduction and buybacks.FIS expects $700 million in added free cash flow by 2028, but slowing growth and integration risks persist.
Fidelity National Information Services, Inc.’s (FIS - Free Report) shares have lost nearly 48% from their 52-week high, reflecting concerns over slowing growth and acquisition-related risks. Yet, improving cash generation and margin expansion suggest that a recovery may not require a sharp acceleration in revenues. The key question is whether FIS can translate its expanded capabilities into sustainable earnings growth while strengthening its balance sheet.
The acquisition of Global Payments' Issuer Solutions business has strengthened FIS' position in issuer processing, creating opportunities for cross-selling and integration savings. Encouragingly, its second-quarter 2026 pro forma adjusted EBITDA margin expanded 113 basis points to 41.7%, indicating progress in profitability. The acquisition is expected to add $700 million in adjusted free cash flow by 2028, supporting longer-term earnings growth alongside established banking relationships and recurring revenues.
FIS’ improving cash generation offers another recovery catalyst. Second-quarter free cash flow surged 220% to $525 million. Stronger cash flow could accelerate deleveraging from its $21.2 billion debt burden and support future share repurchases. However, lowered full-year 2026 forecasts for pro forma revenue growth of 4.5-5% and adjusted EBITDA growth of 5.9-6.9% underscore ongoing execution challenges.
A sustained recovery will depend less on rapid revenue growth and more on turning integration benefits into steady margin gains and lower debt. Progress toward its gross leverage target of approximately 2.8 times could strengthen investor confidence and support a valuation reassessment. Nevertheless, slower growth and integration risks may limit upside until the company demonstrates that its improving profitability and cash conversion are sustainable.
How Are Competitors Faring?Other companies operating in the financial technology space are Fiserv, Inc. (FISV - Free Report) and Jack Henry & Associates, Inc. (JKHY - Free Report) .
Fiserv faces near-term growth challenges, with its 2026 organic revenue outlook ranging from a 1% decline to flat growth. Nevertheless, its merchant and financial solutions franchises provide opportunities to stabilize performance through operational improvements. Fiserv's outlook depends on restoring underlying business momentum.
Jack Henry continues to benefit from financial institutions' investments in modern banking infrastructure and recurring technology services. JKHY’s fiscal 2027 EPS outlook of $7.33-$7.38 indicates further earnings growth, supported by ongoing demand for digital banking solutions.
FIS’ Price Performance, Valuation & EstimatesShares of Fidelity National have lost 70.6% over the past year compared with the industry’s 10.5% decline over the same period.
Image Source: Zacks Investment Research
From a valuation standpoint, FIS trades at a forward price-to-earnings ratio of 5.46, much below the industry average of 18.17. FIS carries a Value Score of A.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for FIS’ 2026 earnings is pegged at $6.20 per share, indicating 7.8% year-over-year growth, followed by an estimated 8.5% increase in 2027.
Image Source: Zacks Investment Research
FIS currently has a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Akcie společnosti Strategy (MSTR) v pátek klesly o 6 % kvůli hrozícímu vyřazení z indexů MSCI, které by podle společnosti mohlo vyvolat odprodej akcií v hodnotě 2,8 miliardy USD.
Strategy (formerly known as MicroStrategy) stock MSTR fell on Friday as investors assessed the potential removal of the Bitcoin treasury company from MSCI's global equity indexes, despite a rise in Bitcoin prices.
The company also announced plans to maintain a 12% annualised dividend rate on its STRC preferred stock for November, subject to shareholder approval and related amendments taking effect.
Strategy shares declined 6% on Friday, while Bitcoin traded around $82,290, having gained more than 1.3% over the previous 24 hours.
Strategy, led by Michael Saylor, is the world's largest corporate Bitcoin holder, with 848,250 BTC.
The stock's decline highlights how factors beyond cryptocurrency prices, including index inclusion and financing costs, can influence investor sentiment towards the company.
MSCI said on Thursday that non-operating companies would be ineligible for its Global Investable Market Indexes from the close of November 30.
The index provider plans to publish the final list of affected companies on November 11.
Strategy and Japan's Metaplanet are among the companies potentially facing removal.
SharpLink and several other cryptocurrency treasury companies are on a watchlist for possible exclusion.
The policy follows a review that MSCI began last year into whether digital asset treasury companies resemble investment funds, which are already excluded from its indexes.
MSCI deferred its original proposal in January before broadening the review to cover non-operating companies more generally.
The potential exclusion matters because passive funds tracking MSCI benchmarks are required to hold constituent stocks.
Strategy previously warned that removal could lead to $2.8 billion worth of its shares being liquidated.
Strategy has disputed MSCI's proposed classification. In a statement on Friday, the company said, “We believe the proposal is misguided.”
Strategy also argued that MSCI's distinction between operating and non-operating companies was undefined and lacked a basis in US GAAP, IFRS or recognised legal frameworks.
The company said funds tracking MSCI's Global Investable Market Indexes held just 3.1% of its outstanding shares, potentially limiting the direct impact of an exclusion.
Strategy maintains 12% STRC dividend rateSeparately, Strategy's board declared daily cash dividends on its STRC preferred stock for each calendar day in November, subject to shareholder approval and the effectiveness of related amendments.
The annualised dividend rate will remain at 12%.
Strategy said management would continue recommending that rate until STRC demonstrates “sustained, healthy trading near $100 per share.”
Payments are scheduled to begin on November 2, with each dividend payable on the business day following its record date, according to a regulatory filing.
STRC is one of Strategy's key fundraising instruments for Bitcoin purchases.
Daily dividend payments could help make the preferred stock more attractive to investors and support trading around its $100 par value.
STRC was down 0.2% at $99.33.
Strategy added 250 Bitcoin for $21.5 million last week, bringing its total holdings to 848,250 BTC.
During the week ending October 4, the company repurchased $176 million worth of STRC, spending more than six times as much on the buybacks as on its $28 million in Bitcoin purchases.
The company introduced a capital framework on June 29 that allows it to sell Bitcoin to fund dividend payments.
It also raised STRC's annual dividend rate to 12% at the time.
Strategy's business model relies on raising capital through stock and debt sales to acquire Bitcoin.
While that approach has made the company a major proxy for cryptocurrency exposure in equity markets, its shares remain sensitive to financing conditions and index-related developments.
Index-related risks like MSCI’s proposed exclusion are closely watched by traders who follow stock reactions through top online trading platforms.
HP (HPQ) má hodnocení Zacks #1 a hodnocení hodnoty A; konsenzuální odhad zisku na akcii pro fiskální rok 2026 se za posledních 60 dní zvýšil o 0,25 USD na 3,23 USD.
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.
Zacks Premium also includes the Zacks Style Scores.
What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.
Each stock is assigned a rating of A, B, C, D, or F based on their value, growth, and momentum characteristics. Just like in school, an A is better than a B, a B is better than a C, and so on -- that means the better the score, the better chance the stock will outperform.
The Style Scores are broken down into four categories:
Value ScoreFor value investors, it's all about finding good stocks at good prices, and discovering which companies are trading under their true value before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and a host of other multiples to help pick out the most attractive and discounted stocks.
Growth ScoreGrowth investors, on the other hand, are more concerned with a company's financial strength and health, and its future outlook. The Growth Style Score examines things like projected and historic earnings, sales, and cash flow to find stocks that will experience sustainable growth over time.
Momentum ScoreMomentum traders and investors live by the saying "the trend is your friend." This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook. Employing factors like one-week price change and the monthly percentage change in earnings estimates, the Momentum Style Score can indicate favorable times to build a position in high-momentum stocks.
VGM ScoreIf you want a combination of all three Style Scores, then the VGM Score will be your friend. It rates each stock on their combined weighted styles, helping you find the companies with the most attractive value, best growth forecast, and most promising momentum. It's also one of the best indicators to use with the Zacks Rank.
How Style Scores Work with the Zacks Rank The Zacks Rank is a proprietary stock-rating model that harnesses the power of earnings estimate revisions, or changes to a company's earnings expectations, to help investors build a successful portfolio.
It's highly successful, with #1 (Strong Buy) stocks producing an unmatched +23.82% average annual return since 1988. That's more than double the S&P 500. But because of the large number of stocks we rate, there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.
But it can feel overwhelming to pick the right stocks for you and your investing goals with over 800 top-rated stocks to choose from.
That's where the Style Scores come in.
To have the best chance of big returns, you'll want to always consider stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B, which will give you the highest probability of success. If you're looking at stocks with a #3 (Hold) rank, it's important they have Scores of A or B as well to ensure as much upside potential as possible.
The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.
For instance, a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one that boasts Scores of A and B, still has a downward-trending earnings forecast, and a much greater likelihood its share price will decline as well.
Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.
Stock to Watch: HP (HPQ - Free Report) Headquartered in Palo Alto, CA, HP Inc. is the surviving entity following the November 2015 split of Hewlett-Packard Company into publicly traded entities, Hewlett Packard Enterprise Company and HP Inc. The undivided entity was founded in 1939.
HPQ is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of B.
It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 9.55; value investors should take notice.
For fiscal 2026, six analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.25 to $3.23 per share. HPQ boasts an average earnings surprise of +9.4%.
With a solid Zacks Rank and top-tier Value and VGM Style Scores, HPQ should be on investors' short list.
Analytici očekávají, že společnost Crown Castle (CCI) vykáže čtvrtletní zisk 1,20 USD na akcii, což představuje meziroční nárůst o 7,1 %, při tržbách ve výši 1,01 miliardy USD, které by měly meziročně klesnout o 5,9 %.
Wall Street analysts expect Crown Castle (CCI - Free Report) to post quarterly earnings of $1.20 per share in its upcoming report, which indicates a year-over-year increase of 7.1%. Revenues are expected to be $1.01 billion, down 5.9% from the year-ago quarter.
The consensus EPS estimate for the quarter has undergone an upward revision of 0.7% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Crown Castle metrics that are commonly monitored and projected by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Revenues- Services and other' of $42.33 million. The estimate points to a change of -29.5% from the year-ago quarter.
Analysts expect 'Revenues- Site rental' to come in at $969.58 million. The estimate indicates a year-over-year change of -4.2%.
The consensus estimate for 'Services and other- Gross margin' stands at $20.48 million. The estimate compares to the year-ago value of $30.00 million.
Based on the collective assessment of analysts, 'Site rental- Gross margin' should arrive at $718.13 million. The estimate is in contrast to the year-ago figure of $762.00 million.
According to the collective judgment of analysts, 'Depreciation, amortization and accretion' should come in at $169.50 million.
The consensus among analysts is that 'Costs of operations- Services and other' will reach $21.85 million.
It is projected by analysts that the 'Costs of operations- Site rental' will reach $251.45 million.
View all Key Company Metrics for Crown Castle here>>>
Shares of Crown Castle have experienced a change of +8.5% in the past month compared to the +2.4% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), CCI is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Akcie společnosti Affirm Holdings za poslední měsíc posílily o 8 %; analytici v aktuálním čtvrtletí očekávají zisk 0,35 USD na akcii, což představuje meziroční nárůst o 52,2 %.
Affirm Holdings (AFRM - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this operator of digital commerce platform have returned +8%, compared to the Zacks S&P 500 composite's +1.4% change. During this period, the Zacks Internet - Software industry, which Affirm Holdings falls in, has gained 5.4%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Affirm Holdings is expected to post earnings of $0.35 per share for the current quarter, representing a year-over-year change of +52.2%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.4%.
The consensus earnings estimate of $1.91 for the current fiscal year indicates a year-over-year change of -65.5%. This estimate has changed +1.8% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $2.87 indicates a change of +50.4% from what Affirm Holdings is expected to report a year ago. Over the past month, the estimate has remained unchanged.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Affirm Holdings.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Revenue Growth ForecastWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Affirm Holdings, the consensus sales estimate for the current quarter of $1.21 billion indicates a year-over-year change of +30%. For the current and next fiscal years, $5.51 billion and $6.9 billion estimates indicate +29.4% and +25% changes, respectively.
Last Reported Results and Surprise HistoryAffirm Holdings reported revenues of $1.17 billion in the last reported quarter, representing a year-over-year change of +33%. EPS of $4.62 for the same period compares with $0.2 a year ago.
Compared to the Zacks Consensus Estimate of $1.11 billion, the reported revenues represent a surprise of +5.23%. The EPS surprise was +1300%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Affirm Holdings is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Affirm Holdings. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.
Analytici očekávají, že Halliburton (HAL) ve 3. čtvrtletí vykáže zisk 0,58 USD na akcii, tedy beze změny oproti stejnému čtvrtletí předchozího roku, při tržbách ve výši 5,59 mld. USD, což představuje meziroční pokles o 0,1 %.
Wall Street analysts forecast that Halliburton (HAL - Free Report) will report quarterly earnings of $0.58 per share in its upcoming release, pointing to no change from the year-ago quarter. It is anticipated that revenues will amount to $5.59 billion, exhibiting a decrease of 0.1% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 0.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some Halliburton metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Revenue- Drilling and Evaluation' at $2.41 billion. The estimate indicates a change of +1.5% from the prior-year quarter.
The consensus estimate for 'Revenue- Completion and Production' stands at $3.16 billion. The estimate suggests a change of -1.8% year over year.
It is projected by analysts that the 'Revenue- Latin America' will reach $1.06 billion. The estimate suggests a change of +6.8% year over year.
The combined assessment of analysts suggests that 'Revenue- Europe/Africa/CIS' will likely reach $924.18 million. The estimate indicates a year-over-year change of +11.6%.
Analysts predict that the 'Revenue- North America' will reach $2.29 billion. The estimate suggests a change of -3% year over year.
The consensus among analysts is that 'Revenue- Middle East/Asia' will reach $1.30 billion. The estimate points to a change of -7.9% from the year-ago quarter.
Analysts forecast 'Operating income- Completion and Production' to reach $515.78 million. The estimate is in contrast to the year-ago figure of $514.00 million.
Based on the collective assessment of analysts, 'Operating income- Drilling and Evaluation' should arrive at $338.14 million. The estimate compares to the year-ago value of $348.00 million.
View all Key Company Metrics for Halliburton here>>>
Over the past month, Halliburton shares have recorded returns of -3.4% versus the Zacks S&P 500 composite's +2.4% change. Based on its Zacks Rank #3 (Hold), HAL will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
SLB ve čtvrtletí končícím v září 2026 očekává zisk 0,62 USD na akcii, což představuje meziroční pokles o 10,1 %, při tržbách ve výši 9,29 miliardy USD (+4 %).
Wall Street expects a year-over-year decline in earnings on higher revenues when SLB (SLB - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on October 23, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis world's largest oilfield services company is expected to post quarterly earnings of $0.62 per share in its upcoming report, which represents a year-over-year change of -10.1%.
Revenues are expected to be $9.29 billion, up 4% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.19% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for SLB?For SLB, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.45%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that SLB will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that SLB would post earnings of $0.51 per share when it actually produced earnings of $0.55, delivering a surprise of +7.84%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
SLB doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsAnother stock from the Zacks Technology Services industry, SLB (SLB - Free Report) , is soon expected to post earnings of $0.62 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -10.1%. Revenues for the quarter are expected to be $9.29 billion, up 4% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for SLB has been revised 2.2% down to the current level. Nevertheless, the company now has an Earnings ESP of -1.45%, reflecting a lower Most Accurate Estimate.
When combined with a Zacks Rank of #3 (Hold), this Earnings ESP makes it difficult to conclusively predict that SLB will beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Shares of uranium miner Cameco (CCJ -0.72%) are down nearly 26% over the last six months -- and 36% off their all-time high. At the same time, uranium trades at a price that, outside of a few temporary spikes, it has never traded at previously.
So why is the premier nuclear company's stock performing so badly, and is this a buying opportunity?
Tailwinds and headwinds
The end market environment is excellent for Cameco. There's no shortage of interest in investing in small modular reactors (SMRs), and hyperscalers continue investing in nuclear power to ensure a reliable long-term supply for their artificial intelligence data centers.
Image source: Getty Images.
Moreover, the upcoming initial public offering of Westinghouse Electric (a nuclear power technology and services provider in which Cameco owns a 49% stake) will release value for Cameco shareholders and give the company access to liquidity should it ever need it.
As for the rising price of uranium, back in July's second-quarter earnings, management raised its expectation for full-year average realized price in its uranium segment (its largest earnings generator) to a range of 91 to 96 Canadian dollars per pound, from a range of CA$85 to CA$89 per pound.
While all of this is good news, the stock's underperformance stems from a perceived failure to capitalize on its environment following the release of a disappointing second-quarter earnings report. Even worse, the declines were across all three segments.
Segment
Adjusted EBITDA Second Quarter 2025
Adjusted EBITDA Second Quarter 2026
Change
Uranium
CA$352 million
CA$252 million
(CA$100 million)
Fuel Services
CA$57 million
CA$42 million
(CA$15 million)
Westinghouse (Cameco Share)
CA$126 million
(CA$10 million)
(CA$136 million)
Data source: Cameco presentations. EBITDA is earnings before interest, taxation, depreciation, and amortization.
Guidance remains good
That said, and somewhat confusingly, management's updated full-year guidance implies it's still on track for a strong year despite the weak second quarter. Starting with Westinghouse, management maintained guidance for full-year EBITDA of $370 million to $430 million.
In the uranium segment, management maintained full-year production guidance of 19.5 million pounds to 21.5 million pounds and delivery volumes of 29 million pounds to 32 million pounds. I've already noted that it raised estimates for an average realized price of uranium in 2026 by as much as CA$6.50, and even though it also raised average uranium unit cost of sales full-year guidance by as much as CA$2.50 to a new range of CA$63 to CA$67.50, it still implies an improving spread.
Finally, in fuel services, management increased the revenue guidance from CA$590 million to CA$630 million, to a new range of CA$610 million to CA$650 million.
With these improvements to the underlying guidance in mind, it appears likely that, provided Cameco maintains this guidance and delivers third-quarter earnings that bolster confidence in the company's ability to do so, the stock has excellent recovery potential.
CCJ Cameco$82.63-$0.60 (-0.72%)
NYSE · As of 11:07 AM ET 10/16/26
What Cameco needs to do to convince investors
In the uranium segment, production volume declined year over year to 3.9 million pounds, with "Spring road conditions" causing "temporary unplanned operational disruptions" and "operational challenges that had Cigar Lake production suspended for a couple of weeks," according to CEO Timothy Gitzel on the earnings call. Still, Gitzel claimed the company was able to overcome these issues "with no impact on annual outlook."
Cameco needs to demonstrate it is on track for its full-year guidance, and with 10.1 million pounds in the first six months, it does appear to be, despite the weak second-quarter production number.
Image source: Getty Images.
The issue at Westinghouse appears to be timing and a tough comparison to a bumper quarter in 2025, driven by a large revenue influx from a reactor project in the Czech Republic. Here, investors will again be looking for a recovery.
As for fuel services, management noted that sales volumes were weaker as customers chose when to receive deliveries, resulting in lumpiness.
Frankly, a lot of factors seemed to come together to give Cameco a weak-looking second quarter, and many of them need to turn around in the third quarter. Still, the end-market backdrop and pricing remain constructive, and the dip in the share price sets the stock up to outperform, given solid third-quarter earnings. That's a favorable scenario for investors.
Společnost Rithm by měla za čtvrtletí končící v září 2026 vykázat EPS ve výši 0,50 USD, což představuje meziroční pokles o 7,4 %, při tržbách 1,49 miliardy USD (+34,5 %).
Wall Street expects a year-over-year decline in earnings on higher revenues when Rithm (RITM - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on October 23, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis real estate investment trust is expected to post quarterly earnings of $0.50 per share in its upcoming report, which represents a year-over-year change of -7.4%.
Revenues are expected to be $1.49 billion, up 34.5% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.52% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Rithm?For Rithm, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.34%.
On the other hand, the stock currently carries a Zacks Rank of #4.
So, this combination makes it difficult to conclusively predict that Rithm will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Rithm would post earnings of $0.5 per share when it actually produced earnings of $0.60, delivering a surprise of +20.00%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Rithm doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerPrimis Financial (FRST - Free Report) , another stock in the Zacks Financial - Miscellaneous Services industry, is expected to report earnings per share of $0.45 for the quarter ended September 2026. This estimate points to a year-over-year change of +60.7%. Revenues for the quarter are expected to be $51.21 million, up 24.9% from the year-ago quarter.
The consensus EPS estimate for Primis Financial has been revised 7.9% higher over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +4.44%.
This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that Primis Financial will beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Analytici očekávají, že Lam Research vykáže čtvrtletní zisk na akcii (EPS) ve výši 2,17 USD, což představuje meziroční nárůst o 72,2 %, při tržbách 8,12 miliardy USD, meziročně vyšších o 52,4 %.
Wall Street analysts forecast that Lam Research (LRCX - Free Report) will report quarterly earnings of $2.17 per share in its upcoming release, pointing to a year-over-year increase of 72.2%. It is anticipated that revenues will amount to $8.12 billion, exhibiting an increase of 52.4% compared to the year-ago quarter.
Over the last 30 days, there has been an upward revision of 0.4% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Lam Research metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Revenue- Customer support-related revenue and other' stands at $2.50 billion. The estimate indicates a change of +40.6% from the prior-year quarter.
The collective assessment of analysts points to an estimated 'Revenue- Systems' of $5.61 billion. The estimate points to a change of +58.3% from the year-ago quarter.
Analysts predict that the 'Leading- and non-leading-edge equipment and upgrade Revenue - Memory' will reach 45.7%. The estimate is in contrast to the year-ago figure of 34.0%.
The average prediction of analysts places 'Leading- and non-leading-edge equipment and upgrade Revenue - Logic/integrated device manufacturing' at 10.7%. The estimate compares to the year-ago value of 6.0%.
Analysts' assessment points toward 'Leading- and non-leading-edge equipment and upgrade Revenue - Foundry' reaching 43.7%. Compared to the present estimate, the company reported 60.0% in the same quarter last year.
View all Key Company Metrics for Lam Research here>>>
Over the past month, shares of Lam Research have returned +3% versus the Zacks S&P 500 composite's +2.4% change. Currently, LRCX carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Carvana (CVNA - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Over the past month, shares of this company have returned -7.9%, compared to the Zacks S&P 500 composite's +1.4% change. During this period, the Zacks Internet - Commerce industry, which Carvana falls in, has gained 1.6%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, Carvana is expected to post earnings of $0.48 per share, indicating a change of +128.6% from the year-ago quarter. The Zacks Consensus Estimate has changed -4% over the last 30 days.
The consensus earnings estimate of $1.65 for the current fiscal year indicates a year-over-year change of -2.4%. This estimate has changed -1.7% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $2.18 indicates a change of +32.2% from what Carvana is expected to report a year ago. Over the past month, the estimate has changed -2.7%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Carvana is rated Zacks Rank #4 (Sell).
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
In the case of Carvana, the consensus sales estimate of $7.62 billion for the current quarter points to a year-over-year change of +35%. The $28.87 billion and $37.01 billion estimates for the current and next fiscal years indicate changes of +42.1% and +28.2%, respectively.
Last Reported Results and Surprise HistoryCarvana reported revenues of $7.38 billion in the last reported quarter, representing a year-over-year change of +52.4%. EPS of $0.42 for the same period compares with $0.26 a year ago.
Compared to the Zacks Consensus Estimate of $6.99 billion, the reported revenues represent a surprise of +5.55%. The EPS surprise was 0%.
Over the last four quarters, Carvana surpassed consensus EPS estimates two times. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Carvana is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Carvana. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term.
Očekává se, že Gentex ve čtvrtletí vykáže zisk 0,51 USD na akcii, což představuje meziroční nárůst o 10,9 %, při tržbách ve výši 669,17 milionu USD (+2,1 %).
Gentex (GNTX - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on October 23, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis maker of automatic-dimming rearview mirrors and other products is expected to post quarterly earnings of $0.51 per share in its upcoming report, which represents a year-over-year change of +10.9%.
Revenues are expected to be $669.17 million, up 2.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.67% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Gentex?For Gentex, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.66%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Gentex will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Gentex would post earnings of $0.5 per share when it actually produced earnings of $0.58, delivering a surprise of +16.00%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Gentex appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
An Industry Player's Expected ResultsAmong the stocks in the Zacks Automotive - Original Equipment industry, Visteon (VC - Free Report) , is soon expected to post earnings of $2.35 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +9.3%. This quarter's revenue is expected to be $936.99 million, up 2.2% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for Visteon has been revised 1.3% down to the current level. Nevertheless, the company now has an Earnings ESP of -4.05%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that Visteon will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Key Takeaways EQT raised its quarterly dividend by 3% to 17 cents per share, bringing its annualized payout to 68 cents.EQT's dividend is payable on Dec. 1, 2026, to shareholders of record as of Nov. 4, 2026.EQT's latest dividend hike extends its pattern of gradually increasing shareholder payouts.
EQT Corporation (EQT - Free Report) has announced a 3% increase in its quarterly cash dividend to 17 cents per common share. The latest hike brings EQT's annualized dividend to 68 cents per share, reflecting its commitment to rewarding shareholders.
The dividend is payable on Dec. 1, 2026, to shareholders of record as of Nov. 4, 2026.
EQT Continues Its Dividend Growth MomentumEQT's latest announcement follows earlier increases in shareholder distributions. The leading U.S. natural gas producer’s quarterly dividend stood at 16.5 cents per share in the second quarter of 2026, up from 15.75 cents in the prior-year period.
The increases demonstrate EQT's commitment to gradually enhancing shareholder payouts.
Strong Cash Generation Supports EQT's DividendEQT generated $330 million in free cash flow attributable to the company during the second quarter of 2026. Its net debt declined to $5.5 billion, strengthening financial flexibility and supporting future capital allocation priorities.
What Supports EQT’s Future Dividend Growth?EQT's low-cost operations, growing natural gas demand and expanding liquefied natural gas exposure offer opportunities to improve future cash generation.
The company's integrated upstream and midstream operations, along with its focus on disciplined spending, further support sustainable shareholder distributions.
EQT’s Zacks Rank & Key PicksEQT currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the energy sector that reward shareholders through regular dividends include Equinor ASA (EQNR - Free Report) , Shell plc (SHEL - Free Report) and Chevron Corporation (CVX - Free Report) . EQNR, SHEL and CVX currently sport a Zacks Rank #1 (Strong Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.
While EQT recently increased its quarterly dividend to 17 cents per share, Equinor maintains a quarterly dividend of 39 cents per share. Similarly, Shell and Chevron have declared quarterly dividends of 39.06 cents per ordinary share and $1.78 per share, respectively.
The business models of EQT, EQNR, SHEL and CVX depend on favorable commodity prices and operating efficiency to support cash generation and sustain shareholder distributions.
Worldcoin (WLD) gained 6.60% to $0.5394 on Coinbase during the October 16 session.
South Korean trading interest intensified, with WLD’s reported domestic trading share reaching 26.5 times its global share.
Derivatives open interest climbed 23.51% to $322.4 million, an increase of approximately $61.4 million in outstanding positions.
WLD faces an immediate test near $0.54, while the rising channel and October 16 low define the downside risk.
Worldcoin (WLD) rallied on October 16 as unusually concentrated South Korean trading activity coincided with a sharp expansion in global derivatives positioning.
At the time of writing WLD trades at $0.5394, gaining 6.60% during the session. The token opened at $0.5058, fell to $0.4925 and subsequently reached an intraday high of $0.5459.
The recovery followed several volatile sessions. Historical market data show that WLD fell approximately 11% on October 12 before recovering part of those losses later in the week.
The latest advance is notable for the scale of the accompanying derivatives expansion. Rather than declining as traders close existing contracts, outstanding positions have increased sharply, suggesting that new speculative exposure is being established during the rebound.
South Korean Trading Interest Accelerates
Worldcoin led South Korea’s domestic cryptocurrency interest index on October 16 with a reported score of 85.6 points, according to TokenPost.
Domestic trading volume reached 89.87 billion won, approximately $65 million, while WLD’s share of Korean cryptocurrency trading was reportedly 26.5 times its corresponding global share.
The concentration points to unusually strong local participation.
A geographical imbalance of this magnitude can influence short-term trading conditions, particularly when local demand is strong enough to attract arbitrage activity between exchanges.
However, the reported ratio compares market shares, not net purchases. High turnover can result from repeated buying and selling of the same tokens.
WLD’s global 24-hour trading volume also increased 36.55% to approximately $399.5 million, indicating that activity expanded beyond the Korean market.
The combination of concentrated domestic interest and rising global turnover provides a credible explanation for the increased attention surrounding WLD, although neither measure independently establishes the direction of net capital flows.
WLD Open Interest Expands by $61 Million
Derivatives data from Coinalyze provides a more direct measure of changing market participation.
The supplied market snapshot shows total WLD open interest increasing 23.51% over 24 hours to $322.4 million.
That implies approximately $261 million in outstanding positions a day earlier, meaning the reported dollar value of open interest expanded by roughly $61.4 million.
The exchange breakdown reveals a highly concentrated derivatives market.
Binance accounts for $111.9 million, followed by Bybit at $90.9 million, Hyperliquid at $79.1 million and OKX at $37.2 million. Together, those four venues represent approximately 99% of reported open interest.
WLD / Derivatives Monitor
Where Traders Hold WLD Exposure
Exchange-level open interest · October 16, 2026
Total Open Interest
$322.4M
24H Change
+23.51%
Market Share Distribution
% of reported OI
Binance, Bybit and Hyperliquid account for approximately 87.4% of reported positions.
Binance
34.7%
$111.9M
Bybit
28.2%
$90.9M
Hyperliquid
24.5%
$79.1M
OKX
11.5%
$37.2M
Values calculated from the supplied derivatives snapshot. Exchange shares are rounded; remaining venues account for approximately 1.1%.
The increase contrasts with WLD’s October 10 advance, when Binance futures open interest declined 9.33% as prices rose. That earlier combination was consistent with traders closing existing positions, including potential short covering.
The latest expansion suggests a different trading environment.
Rising prices alongside higher open interest indicate growing participation, but they do not establish that bullish positions dominate. Every new derivatives contract involves both a buyer and a seller.
Funding rates would help clarify which side is paying to maintain exposure. Without synchronized funding data across the leading exchanges, the increase in open interest is best interpreted as expanding speculative activity rather than proof of an overcrowded long trade.
The practical consequence is greater sensitivity to sudden price changes if leveraged positions become concentrated.
WLD Tests Fibonacci Resistance Near $0.54
Worldcoin’s daily chart shows an ascending channel that has guided the recovery since September.
The latest rebound developed near the channel’s lower boundary, bringing WLD back toward the 23.6% Fibonacci retracement at $0.5431.
Worldcoin trades near $0.54 within an ascending channel, with RSI and MACD signaling mixed momentum. Source: TradingView, Chart by Alexander Zdravkov
That level is calculated from the broader swing between $0.2933 and $0.6203.
WLD briefly exceeded the retracement during the October 16 session, but the quoted price remained slightly below it at the chart’s timestamp.
Two technical scenarios now define the near-term setup.
Bullish continuation: A sustained daily close above the $0.5431–$0.5459 resistance area would strengthen the recovery and bring the upper portion of the ascending channel back into focus. The previous swing high at $0.6203 remains the broader upside reference.
Bearish breakdown: A daily close below the October 16 low of $0.4925, accompanied by a break of the rising channel boundary, would undermine the current stabilization attempt. The 50% Fibonacci retracement at $0.4568 would then become a relevant lower reference.
The $0.50 region is particularly important because recent price action has repeatedly tested that area and the channel’s rising support line passes nearby.
Momentum indicators remain mixed.
The relative strength index stands at 55.10, slightly below its moving average of 55.92. Meanwhile, the MACD line at 0.0160 remains below its signal line at 0.0230, producing a negative histogram of approximately -0.0069.
The RSI reading shows that WLD has recovered above the neutral midpoint, while MACD indicates that upside momentum has not yet regained its earlier strength.
That divergence makes the current resistance test more significant than the percentage gain alone.
Worldcoin’s Unlock Schedule Adds a Supply Consideration
Worldcoin’s derivatives expansion is occurring alongside continued scheduled token releases.
According to World’s official tokenomics announcement, the daily WLD unlock rate decreased approximately 43% on July 24, 2026, from 5.1 million to 2.9 million tokens.
The reduction included community allocations falling from 3.2 million to 1.6 million WLD per day, while investor and team allocations declined from 1.9 million to 1.3 million.
The project uses continuous daily unlocks rather than a single monthly release event.
At the October 16 quoted price, the current scheduled rate represents approximately $1.56 million in notional token value per day, or $46.9 million over 30 days.
These figures measure the value of tokens becoming unlocked, not confirmed exchange sales. The distinction is especially relevant because World’s tokenomics whitepaper separates unlocked supply from circulating supply, with some unlocked tokens remaining outside active circulation.
The slower unlock schedule reduces the pace at which restrictions expire, but existing circulating tokens and future releases remain part of WLD’s supply outlook.
For traders, the immediate assessment is more narrowly defined.
WLD has recovered toward $0.54 while South Korean activity remains concentrated and global derivatives exposure expands. A confirmed break above the latest intraday high would strengthen the bullish price structure, while a loss of $0.4925 alongside the ascending channel would favor renewed downside pressure.
Alexander Zdravkov is a crypto journalist and market analyst specializing in digital assets, blockchain technology, and the rapidly evolving cryptocurrency market. He entered the industry more than four years ago, drawn to the speed of innovation in crypto and the potential of blockchain-based financial systems to reshape traditional markets.
His work focuses on understanding the forces behind crypto market movements, from Bitcoin and altcoin cycles to institutional adoption, regulation, exchange-traded products, stablecoins, DeFi, and emerging blockchain ecosystems. Rather than simply following price action, Alexander looks at liquidity, investor positioning, market structure, and macroeconomic conditions to identify developing trends and explain what they could mean for digital assets.
With a degree in International Relations, he brings a broader perspective to cryptocurrency coverage by connecting developments in the sector with monetary policy, geopolitics, regulation, and global capital flows. This allows him to examine crypto not as an isolated market, but as an increasingly interconnected part of the global financial system.
Over the course of more than five years in financial journalism, Alexander has written over 5,000 articles covering cryptocurrencies, blockchain, traditional markets, and the global economy. His reporting spans Bitcoin, Ethereum and altcoins, DeFi protocols, institutional crypto adoption, regulation, market infrastructure, security incidents, and major developments shaping the wider digital asset industry.
His approach is centered on giving readers context behind the numbers and headlines, explaining not only what is happening in crypto markets, but why it matters and what could come next.
Southern Co. (SO - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this power company have returned +2.8%, compared to the Zacks S&P 500 composite's +1.4% change. During this period, the Zacks Utility - Electric Power industry, which Southern Co. falls in, has gained 1%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Southern Co. is expected to post earnings of $1.70 per share for the current quarter, representing a year-over-year change of +6.3%. Over the last 30 days, the Zacks Consensus Estimate has changed -14.4%.
The consensus earnings estimate of $4.59 for the current fiscal year indicates a year-over-year change of +6.7%. This estimate has changed +0.1% over the last 30 days.
For the next fiscal year, the consensus earnings estimate of $4.92 indicates a change of +7% from what Southern Co. is expected to report a year ago. Over the past month, the estimate has remained unchanged.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Southern Co. is rated Zacks Rank #3 (Hold).
Revenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For Southern Co., the consensus sales estimate for the current quarter of $8.42 billion indicates a year-over-year change of +7.7%. For the current and next fiscal years, $31.02 billion and $32.91 billion estimates indicate +5% and +6.1% changes, respectively.
Last Reported Results and Surprise HistorySouthern Co. reported revenues of $6.98 billion in the last reported quarter, representing a year-over-year change of +0.1%. EPS of $1.13 for the same period compares with $0.91 a year ago.
Compared to the Zacks Consensus Estimate of $7.36 billion, the reported revenues represent a surprise of -5.18%. The EPS surprise was +11.88%.
Over the last four quarters, Southern Co. surpassed consensus EPS estimates three times. The company topped consensus revenue estimates three times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Southern Co. is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Southern Co.. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Tržby divize U.S. Industrial Services EMCOR ve 2. čtvrtletí 2026 vzrostly meziročně o 25,9 % na 353,8 mil. USD a provozní zisk dosáhl 9,6 mil. USD po loňské ztrátě.
Key Takeaways EMCOR's U.S. Industrial Services revenues climbed 25.9% to $353.8 million in the second quarter of 2026.The segment returned to profitability, posting $9.6 million in operating income versus a $0.4 million loss.Higher turnaround activity, petrochemical project volume and progress on a large solar project drove growth.
EMCOR Group Inc. (EME - Free Report) is benefiting from demand for industrial field services, including maintenance, turnaround work and projects across petrochemical and other industrial markets. The pace of project activity and the ability to convert higher revenues into operating profits remain important factors for the segment's performance.
In the second quarter of 2026, EMCOR's U.S. Industrial Services revenues rose 25.9% year over year to $353.8 million. The segment returned to profitability, generating operating income of $9.6 million in contrast to a loss of $0.4 million in the prior-year quarter. Its operating margin improved to 2.7% from negative 0.1%, reflecting better profitability alongside higher revenues.
Higher turnaround activity and increased petrochemical project volume supported the segment's growth. Progress on a large solar project also contributed to activity. These drivers point to demand across several types of industrial work, although the available figures do not quantify each project's individual contribution to revenues or earnings.
The improvement in operating results provides a stronger starting point for the segment, but profitability remains an important consideration as activity expands. The difference between revenue growth and the operating margin shows why execution and cost control matter alongside project volume. Further progress will depend on the level and mix of industrial work and the segment's ability to translate that activity into operating income.
EMCOR's Industrial Services business has delivered stronger revenues and returned to operating profitability. The extent to which turnaround and petrochemical activity support further improvement will be an important factor in assessing the segment's performance.
EMCOR and Its Key Infrastructure CompetitorsEMCOR competes closely with Quanta Services, Inc. (PWR - Free Report) and MasTec, Inc. (MTZ - Free Report) in the infrastructure and engineering construction market.
Quanta operates across utility, technology and load center markets, providing electrical, mechanical, civil and fabrication services. The company’s broad capabilities and long-standing customer relationships support its position in large and complex infrastructure projects. Quanta is also expanding across technology, power generation and utility markets, increasing exposure to several major infrastructure investment areas. However, exposure to utility capital spending and the timing of large project awards can affect the pace of growth.
MasTec maintains a diversified infrastructure platform spanning telecommunications, power delivery, clean energy and infrastructure, pipeline and mission-critical construction. This broad exposure allows MasTec to benefit from multiple infrastructure investment themes, including data center development, grid modernization, power generation and natural gas infrastructure. However, project timing across individual end markets can create variability, as seen with near-term deferrals in Communications despite strength across Power Delivery, Pipeline and Clean Energy & Infrastructure.
EME Stock’s Price Performance & Valuation TrendShares of this Connecticut-based infrastructure service provider have gained 19.7% year to date, outperforming the Zacks Building Products - Heavy Construction industry, the Zacks Construction sector and the S&P 500 Index.
EME Price Performance (YTD)
Image Source: Zacks Investment Research
EME stock is currently trading at a premium compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 20.16, as evidenced by the chart below.
EME Valuation (P/E F12M)
Image Source: Zacks Investment Research
Earnings Estimate Revision of EMEEME’s earnings estimates for 2026 and 2027 have remained unchanged in the past 30 days at $32.98 and $37.23 per share, respectively. The estimates for 2026 and 2027 imply year-over-year growth of 27.5% and 12.9%, respectively.
Image Source: Zacks Investment Research
EMCOR stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Vertex Pharmaceuticals (VRTX - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this drugmaker have returned -1.5%, compared to the Zacks S&P 500 composite's +1.4% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Vertex falls in, has lost 0.5%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Revisions to Earnings EstimatesRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
Vertex is expected to post earnings of $4.92 per share for the current quarter, representing a year-over-year change of +2.5%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.6%.
For the current fiscal year, the consensus earnings estimate of $18.9 points to a change of +2.7% from the prior year. Over the last 30 days, this estimate has changed +0.4%.
For the next fiscal year, the consensus earnings estimate of $20.61 indicates a change of +9.1% from what Vertex is expected to report a year ago. Over the past month, the estimate has changed +0.7%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Vertex is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of Vertex, the consensus sales estimate of $3.4 billion for the current quarter points to a year-over-year change of +10.6%. The $13.22 billion and $14.67 billion estimates for the current and next fiscal years indicate changes of +10.1% and +11%, respectively.
Last Reported Results and Surprise HistoryVertex reported revenues of $3.33 billion in the last reported quarter, representing a year-over-year change of +12.5%. EPS of $4.73 for the same period compares with $4.52 a year ago.
Compared to the Zacks Consensus Estimate of $3.23 billion, the reported revenues represent a surprise of +3.32%. The EPS surprise was -1.25%.
Over the last four quarters, Vertex surpassed consensus EPS estimates two times. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Vertex is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Vertex. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Analytici očekávají, že společnost CACI International vykáže čtvrtletní EPS ve výši 6,45 USD, což představuje meziroční pokles o 5,8 %, při tržbách ve výši 2,5 miliardy USD, meziročně vyšších o 9,2 %.
In its upcoming report, CACI International (CACI - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $6.45 per share, reflecting a decline of 5.8% compared to the same period last year. Revenues are forecasted to be $2.5 billion, representing a year-over-year increase of 9.2%.
The consensus EPS estimate for the quarter has been revised 1.7% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
In light of this perspective, let's dive into the average estimates of certain CACI International metrics that are commonly tracked and forecasted by Wall Street analysts.
The combined assessment of analysts suggests that 'Revenues by Expertise or Technology- Expertise' will likely reach $978.43 million. The estimate suggests a change of -0.9% year over year.
Analysts expect 'Revenues by Customer Group- Federal Civilian Agencies' to come in at $427.55 million. The estimate indicates a year-over-year change of +3.8%.
According to the collective judgment of analysts, 'Revenues by Customer Group- Department of Defense' should come in at $1.30 billion. The estimate indicates a change of +10.3% from the prior-year quarter.
The consensus among analysts is that 'Revenues by Expertise or Technology- Technology' will reach $1.53 billion. The estimate indicates a year-over-year change of +17.3%.
Analysts' assessment points toward 'Total Revenue - Organic Growth (YOY)' reaching 1.9%. Compared to the present estimate, the company reported 5.5% in the same quarter last year.
View all Key Company Metrics for CACI International here>>>
Shares of CACI International have experienced a change of -3.7% in the past month compared to the +2.4% move of the Zacks S&P 500 composite. With a Zacks Rank #2 (Buy), CACI is expected to outperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Celsius Holdings čelí hromadné žalobě kvůli údajnému zamlčení srdečních rizik nápojů Alani Nu; akcie 4. června 2026 po oznámení vyšetřování v Texasu klesly o 7,53 %.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Celsius Holdings To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Celsius Holdings between February 21, 2025 and June 3, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - October 16, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Celsius Holdings, Inc. ("Celsius Holdings" or the "Company") (NASDAQ: CELH) and reminds investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Defendants' products failed to adequately disclose the cardiac risks of consuming Alani Nu products; (ii) by marketing Alani Nu drinks to consumers under the age of 18, the Company was marketing its products to individuals who were particularly susceptible to known health risks posed by those products; (iii) the foregoing created a non-speculative risk that Alani Nu consumers would suffer potentially fatal adverse health events; (iv) the foregoing, once revealed, was likely to have a significant negative impact on the Company's business and reputation; and (v) as a result, Defendants' public statements were materially false and misleading at all relevant times.
On April 9, 2026, NBC News and local news outlet MyRGV reported that the family of 17-year old Texas cheerleader Larissa Rodriguez had filed a wrongful death lawsuit against distributors of Alani Nu, alleging that Rodriguez died from an enlarged heart caused by drinking Alani Nu energy drinks and that the drinks "had inadequate warnings about the serious cardiac risks" of drinking Alani Nu. On this news, Celsius's stock price fell $1.52 per share, or 4.18%, to close at $34.86 per share on April 10, 2026.
On June 4, 2026, Texas Attorney General Ken Paxton announced an investigation into Celsius over concerns that its high-caffeine energy drinks are being marketed to children and teens, specifically examining whether Celsius and its Alani Nu subsidiary had violated the Texas Deceptive Trade Practices Act by misrepresenting the safety of their products. On news of the investigation, Celsius's stock price fell $2.26 per share, or 7.53%, to close at $27.75 per share on June 4, 2026.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Celsius Holdings's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Celsius Holdings class action, go to www.faruqilaw.com/CELH or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the Celsius Holdings Securities Class Action Lawsuit:
What is the Celsius Holdings securities fraud lawsuit about?
A securities fraud class action lawsuit has been filed against Celsius Holdings, Inc. (NASDAQ: CELH) on behalf of investors who purchased the company's securities during the Class Period. The lawsuit alleges that Defendants made false and/or misleading statements and failed to disclose that Alani Nu products did not adequately warn consumers of cardiac risks associated with their consumption, and that the company allegedly marketed those products to individuals under the age of 18 who were particularly susceptible to those known health risks. The complaint further alleges that these undisclosed facts created a non-speculative risk that Alani Nu consumers could suffer potentially fatal adverse health events. On April 9, 2026, news reports emerged about a wrongful death lawsuit filed by the family of a 17-year-old Texas cheerleader who allegedly died from an enlarged heart attributed to Alani Nu consumption, causing Celsius's stock to decline approximately 4.18%. The allegations were compounded on June 4, 2026, when the Texas Attorney General announced an investigation into whether Celsius and its Alani Nu subsidiary violated the Texas Deceptive Trade Practices Act by misrepresenting product safety, causing a further stock decline of approximately 7.53%.
Who may be eligible to participate in the lawsuit?
Investors who purchased or otherwise acquired securities of Celsius Holdings, Inc. (NASDAQ: CELH) on the NASDAQ exchange between February 21, 2025 and June 3, 2026, inclusive, may be eligible to participate in this class action lawsuit. Eligibility to participate is not limited to those who apply to serve as lead plaintiff; any investor who purchased Celsius Holdings securities during the Class Period and suffered losses may potentially share in any recovery obtained. Investors are encouraged to review their trading records to determine whether their purchases fall within the defined Class Period. Those with questions about their eligibility are encouraged to consult with counsel to evaluate their options.
What is a lead plaintiff, and how can I seek appointment?
A lead plaintiff is a court-appointed representative who serves on behalf of all class members and plays an active role in overseeing the litigation, including working with counsel to direct the prosecution of the case. Under the Private Securities Litigation Reform Act, any member of the proposed class may move the court for appointment as lead plaintiff, and the court generally appoints the movant with the largest financial interest in the relief sought who also satisfies applicable legal requirements. The deadline to file a motion for appointment as lead plaintiff is the lead plaintiff deadline applicable to this case, and investors wishing to be considered for this role must act before that date. Importantly, investors are not required to seek appointment as lead plaintiff in order to participate in the lawsuit or to share in any monetary recovery that may result. Those interested in the lead plaintiff role are encouraged to consult with qualified securities litigation counsel promptly to allow sufficient time to prepare and file the necessary motion.
Why should investors contact Faruqi & Faruqi, LLP?
Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Celsius Holdings securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/319248
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Akcie Clear Secure za poslední měsíc vzrostly o 12,2 %, zatímco odhad zisku na akcii (EPS) pro letošní rok zůstává na úrovni 2,20 USD. Zacks jim udělil hodnocení č. 3 („držet“).
Clear Secure (YOU - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Shares of this airport security company have returned +12.2% over the past month versus the Zacks S&P 500 composite's +1.4% change. The Zacks Internet - Software industry, to which Clear Secure belongs, has gained 5.4% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, Clear Secure is expected to post earnings of $0.56 per share, indicating a change of +93.1% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $2.2 points to a change of +96.4% from the prior year. Over the last 30 days, this estimate has remained unchanged.
For the next fiscal year, the consensus earnings estimate of $2.83 indicates a change of +28.6% from what Clear Secure is expected to report a year ago. Over the past month, the estimate has remained unchanged.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Clear Secure.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
In the case of Clear Secure, the consensus sales estimate of $286.49 million for the current quarter points to a year-over-year change of +25%. The $1.11 billion and $1.3 billion estimates for the current and next fiscal years indicate changes of +23.1% and +17.1%, respectively.
Last Reported Results and Surprise HistoryClear Secure reported revenues of $277.76 million in the last reported quarter, representing a year-over-year change of +26.6%. EPS of $0.49 for the same period compares with $0.26 a year ago.
Compared to the Zacks Consensus Estimate of $269.9 million, the reported revenues represent a surprise of +2.91%. The EPS surprise was +22.5%.
Over the last four quarters, Clear Secure surpassed consensus EPS estimates three times. The company topped consensus revenue estimates each time over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Clear Secure is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Clear Secure. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
Truist Financial ve čtvrtletí vykázala upravený zisk 1,16 USD na akcii, pod odhadem 1,17 USD na akcii; tržby ve výši 5,19 miliardy USD zaostaly za konsensem o 2,19 %.
Truist Financial Corporation (TFC - Free Report) came out with quarterly earnings of $1.16 per share, missing the Zacks Consensus Estimate of $1.17 per share. This compares to earnings of $1.04 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -0.86%. A quarter ago, it was expected that this company would post earnings of $1.08 per share when it actually produced earnings of $1.23, delivering a surprise of +13.89%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Truist Financial, which belongs to the Zacks Banks - Major Regional industry, posted revenues of $5.19 billion for the quarter ended September 2026, missing the Zacks Consensus Estimate by 2.19%. This compares to year-ago revenues of $5.19 billion. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Truist Financial shares have lost about 5.4% since the beginning of the year versus the S&P 500's gain of 13.1%.
What's Next for Truist Financial?While Truist Financial has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Truist Financial was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.21 on $5.29 billion in revenues for the coming quarter and $4.67 on $21.03 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Major Regional is currently in the bottom 33% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Northern Trust Corporation (NTRS - Free Report) , another stock in the same industry, has yet to report results for the quarter ended September 2026. The results are expected to be released on October 21.
This company is expected to post quarterly earnings of $2.86 per share in its upcoming report, which represents a year-over-year change of +24.9%. The consensus EPS estimate for the quarter has been revised 0.8% higher over the last 30 days to the current level.
Northern Trust Corporation's revenues are expected to be $2.26 billion, up 11.8% from the year-ago quarter.
The upcoming report from Kinder Morgan (KMI - Free Report) is expected to reveal quarterly earnings of $0.33 per share, indicating an increase of 13.8% compared to the year-ago period. Analysts forecast revenues of $4.38 billion, representing an increase of 5.7% year over year.
Over the last 30 days, there has been an upward revision of 0.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
Bearing this in mind, let's now explore the average estimates of specific Kinder Morgan metrics that are commonly monitored and projected by Wall Street analysts.
The consensus among analysts is that 'Realized weighted average oil price' will reach 71 dollars per barrel. The estimate is in contrast to the year-ago figure of 68 dollars per barrel.
It is projected by analysts that the 'Realized weighted average NGL price' will reach 35 dollars per barrel. The estimate compares to the year-ago value of 31 dollars per barrel.
The average prediction of analysts places 'Terminals - Liquids leasable capacity' at N/A. The estimate is in contrast to the year-ago figure of N/A.
Analysts predict that the 'NGL sales volumes - net' will reach 9.80 thousands of barrels of oil per day. The estimate is in contrast to the year-ago figure of 9.03 thousands of barrels of oil per day.
Analysts expect 'Total oil production - net' to come in at 28.20 thousands of barrels of oil per day. The estimate is in contrast to the year-ago figure of 25.04 thousands of barrels of oil per day.
According to the collective judgment of analysts, 'Terminals - Bulk transload tonnage' should come in at 13 millions of ton. Compared to the present estimate, the company reported 12 millions of ton in the same quarter last year.
The consensus estimate for 'Segment EBDA- Natural gas Pipelines' stands at $1.41 billion. Compared to the present estimate, the company reported $1.39 billion in the same quarter last year.
Analysts forecast 'Segment EBDA- Terminals' to reach $284.75 million. The estimate is in contrast to the year-ago figure of $274.00 million.
Based on the collective assessment of analysts, 'Segment EBDA- Products Pipelines' should arrive at $290.54 million. The estimate compares to the year-ago value of $288.00 million.
The collective assessment of analysts points to an estimated 'Segment EBDA- CO2' of $195.07 million. Compared to the present estimate, the company reported $135.00 million in the same quarter last year.
View all Key Company Metrics for Kinder Morgan here>>>
Shares of Kinder Morgan have demonstrated returns of +4.8% over the past month compared to the Zacks S&P 500 composite's +2.4% change. With a Zacks Rank #3 (Hold), KMI is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Fox Factory po odchodu Mikea Dennisona jmenovala nezávislého ředitele Douglase Grimma prozatímním výkonným ředitelem a snížila výhled tržeb pro fiskální rok 2026 na 1,35 až 1,38 mld. USD.
Independent Director Douglas Grimm Appointed Interim CEO; Board Initiates Search for Permanent CEOLeadership Team Focused on Customer-Led Product Innovation, Margin Improvement, Free Cash Flow and Return on Invested Capital Preliminary Third Quarter Fiscal 2026 Results Below Expectations; Updates Fiscal 2026 Outlook for Divestiture of Marucci and Operating Performance; Schedules Earnings Conference Call for November 5, 2026 DULUTH, Ga., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Fox Factory Holding Corp. (NASDAQ: FOXF) (“FOX” or the “Company”), a premium brand and a global leader in the design, engineering and manufacturing of performance-defining products and systems for customers worldwide, today announced that its Board of Directors (the “Board”) has decided to make a leadership change. Effective October 16, 2026, the Board has appointed independent director Douglas (“Doug”) Grimm as Interim Chief Executive Officer, and Mike Dennison is stepping down from his role as CEO and a member of the Board.
The Board has retained Heidrick & Struggles, a leading executive search firm, to assist in identifying a permanent CEO. The search will be led by Chair Jean Hlay and directors Tom Duncan and Doug Grimm. Mr. Grimm, who is not a candidate for the permanent CEO role, will step down from the Audit Committee, but will remain on the Board and continue to serve on the Transformation Committee. Alan Bazaar will succeed Mr. Grimm as Chair of the Audit Committee. The Company’s leadership team, including Chief Financial Officer Dennis Schemm, who leads the Company’s profit optimization program, will continue to drive customer-led product innovation and growth.
“Doug is an accomplished executive with more than four decades of operating experience in the automotive and industrial sectors, and we are confident he is the right interim leader to accelerate execution in our businesses,” said Jean Hlay, Chair of the Board. “He has not only led multiple, successful transformations but also brings a deep understanding of our company’s heritage and the operational improvements we are executing on to reach our full potential. The Board and I look forward to working with him in this new capacity while we conduct a rigorous search for a permanent leader.”
“FOX has earned its place as a leader in the powered vehicle and bike markets through an unwavering commitment to innovating performance-defining products for professional athletes and enthusiasts,” said Mr. Grimm. “It is an honor to serve as Interim CEO at this important moment in FOX’s trajectory. Through my work on the Transformation Committee, I have seen firsthand how FOX’s talented team is actively working to deliver the best products and improve our financial position. I look forward to working closely with Dennis and our leadership team to execute on our strategy and advance a culture of excellence that our customers rely on.”
“On behalf of the Board, I also want to thank Mike for his many contributions to FOX over the last seven years,” added Ms. Hlay. “Mike helped build FOX into a precision engineering company with strong brands and great products. His focus on engineering and innovation earned the loyalty of our OEM partners, athletes and enthusiasts who depend on our products.”
“It has been a privilege to lead FOX since 2019 and navigate periods of significant change in partnership with such a talented team,” said Mr. Dennison. “I am proud of what we accomplished together and look forward to supporting Doug and the team through the transition.”
Doug Grimm Bio
Mr. Grimm is a seasoned operator with more than 40 years of experience in the automotive and industrial tech sectors, including as President and Chief Operating Officer of Metaldyne Performance Group Inc., an automotive metals supplier with 60 manufacturing plants in 13 countries; as Chairman of Electrical Components International (ECI), a global manufacturer of electrical distribution systems; and as Founder, Chairman and CEO of Grede Holdings LLC, a leading manufacturer of safety-critical iron castings. Over his career, he led business transformations, integrations and more than 40 transactions. He currently serves as Chairman of the Board of Blue Bird Corporation (NASDAQ: BLBD) and as a member of the Board of Directors of Lucid Group, Inc. (NASDAQ: LCID).
Preliminary Third Quarter Fiscal 2026 Results
Based on preliminary unaudited information, the Company expects to report the following for the third quarter of fiscal 2026 ended October 2, 2026:
Net sales of $336 million to $340 million, compared to guidance of $355 million to $380 million. Net sales include approximately $33 million from Marucci Sports through the September 25, 2026 closing of the divestiture, compared to approximately $46 million assumed in guidance for the full quarter.Adjusted EBITDA of $38 million to $42 million, excluding approximately $12 million of IEEPA tariff refunds received in the quarter, compared to guidance of $46 million to $54 million, which did not include any tariff refunds. Third quarter results were below the Company’s expectations, primarily due to lower sales and margin at Marucci Sports, which did not deliver to expectations prior to the closing; lower than expected sales and margins in the Powered Vehicles Group driven by a supply disruption and the associated higher operating costs, and unfavorable mix; operating challenges within the Aftermarket Applications Group in its upfit business; and to a lesser extent, softer than expected bike sales in the Specialty Sports Group.
The preliminary results above are based on information available to the Company as of the date of this release and are subject to completion of the Company’s quarter-end financial close procedures. Actual results may differ from these preliminary results. The Company’s independent registered public accounting firm has not audited, reviewed, compiled, or applied agreed-upon procedures with respect to the preliminary financial data. Accordingly, the Company’s independent registered public accounting firm does not express an opinion or any other form of assurance with respect thereto. Complete results will be included in the Company’s Quarterly Report on Form 10-Q for the quarter ended October 2, 2026.
Fourth Quarter and Fiscal 2026 Outlook
The Company is lowering its outlook for the fourth quarter of fiscal 2026:
Net sales of $287 million to $313 million, in line with prior underlying guidance for its remaining core businesses, excluding Marucci Sports.Adjusted EBITDA of $23 million to $29 million, excluding Marucci Sports. Relative to prior implied assumptions for the fourth quarter, the updated adjusted EBITDA assumption reflects the divestiture of Marucci Sports, a continuation of the supply disruption and higher than anticipated inflation in steel, aluminum and freight costs in the Powered Vehicles Group, and within the Aftermarket Applications Group lower chassis availability and continued operational challenges in the upfit business; at the segment level, adjusted EBITDA margin for the Powered Vehicles Group and Aftermarket Applications Group is expected to be approximately flat versus the fourth quarter of 2025. The Company is lowering its fiscal 2026 outlook to reflect preliminary third quarter results, the divestiture of Marucci Sports on September 25, 2026, and updated expectations for the fourth quarter. For fiscal 2026, the Company now expects:
Net sales of $1.35 billion to $1.38 billion, compared to prior guidance of $1.42 billion to $1.47 billion. Approximately $63 million of the reduction reflects Marucci Sports, including approximately $50 million of fourth quarter net sales included in prior guidance.Adjusted EBITDA of $140 million to $150 million, excluding approximately $14 million of IEEPA tariff refunds received in the second and third quarters, compared to prior guidance of $176 million to $196 million.Adjusted EBITDA, including IEEPA tariff refunds, in the range of $154 million to $164 million. The outlook reflects input costs at current levels, including the aluminum, steel and freight inflation described above, and assumes no further increases. The Company has received the majority of the IEEPA tariff refunds it expects, and the outlook does not include any additional refunds.
FOX FACTORY HOLDING CORP.
NET SALES EXCLUDING MARUCCI SPORTS
(in millions)
(unaudited) Fiscal
Prior outlook
Preliminary / updated
2025 LowHighLowHighThird quarter Net sales, as reported / outlook$376 $355 $380 $336 $340 Less: Marucci Sports (49) (44) (48) (33) (33)Net sales excluding Marucci Sports$327 $311 $332 $303 $307 Fiscal year Net sales, as reported / outlook$1,467 $1,420 $1,470 $1,350 $1,380 Less: Marucci Sports (186) (172) (180) (113) (113)Net sales excluding Marucci Sports$1,281 $1,248 $1,290 $1,237 $1,267 Marucci Sports net sales for fiscal 2025 and the first six months of fiscal 2026 are as presented in the unaudited pro forma condensed consolidated financial information filed as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed on September 29, 2026. Third quarter fiscal 2025 Marucci Sports net sales are derived from the Company’s internal records. Fiscal 2026 amounts include Marucci Sports net sales through the September 25, 2026 closing of the divestiture. Net sales excluding Marucci Sports is a non-GAAP financial measure presented to help investors compare the Company’s net sales with prior periods on a consistent basis. Amounts may not sum due to rounding.
Available Information
Fox Factory Holding Corp. announces material information to the public about the Company through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls, webcasts, and the Investor Relations section of its website (https://investor.ridefox.com) in order to achieve broad, non-exclusionary distribution of information to the public and for complying with its disclosure obligations under Regulation FD.
About Fox Factory Holding Corp. (NASDAQ: FOXF)
Fox Factory Holding Corp. is a global leader in the design, engineering, and manufacturing of premium products that deliver championship-level performance for specialty sports and on- and off-road vehicles. Its portfolio of brands, like FOX, Method Race Wheels, and more, are fueled by unparalleled innovation that continuously earns the trust of professional athletes and passionate enthusiasts all around the world. The Company is a direct supplier of shocks, suspension, and components to leading powered vehicle and bicycle original equipment manufacturers (OEMs). The Company also provides products in the aftermarket through its global network of retailers and distributors and through direct-to-consumer channels.
FOX is a registered trademark of Fox Factory, Inc. NASDAQ Global Select Market is a registered trademark of The NASDAQ OMX Group, Inc. All rights reserved.
Non-GAAP Financial Measures
This release includes adjusted EBITDA, adjusted EBITDA excluding IEEPA tariff refunds and net sales excluding Marucci Sports, which are non-GAAP financial measures. Net sales excluding Marucci Sports is reconciled to net sales, the most directly comparable GAAP measure, in the net sales table above, and adjusted EBITDA excluding IEEPA tariff refunds is reconciled to adjusted EBITDA in the preliminary results and outlook above. The Company has not provided a reconciliation of preliminary third quarter adjusted EBITDA or fiscal 2026 adjusted EBITDA outlook to net income, the most directly comparable GAAP measure, because the Company has not completed its quarter-end financial close procedures and certain reconciling items cannot be reasonably predicted without unreasonable effort. The Company will provide a reconciliation of third quarter adjusted EBITDA to net income in its third quarter fiscal 2026 earnings release.
Certain statements in this press release may be deemed to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends that all such statements be subject to the “safe-harbor” provisions contained in those sections. Forward-looking statements include, but are not limited to, statements regarding the Company’s leadership transition and the search for a permanent Chief Executive Officer; preliminary financial results for the third quarter of fiscal 2026; the Company’s outlook for the fourth quarter and fiscal 2026, including the assumptions underlying the outlook regarding input costs and IEEPA tariff refunds; the expected impact of the divestiture of Marucci Sports on the Company’s future results; the Company’s profit optimization program and its ability to drive customer-led product innovation and growth; and the timing of the Company’s third quarter earnings release and conference call. These statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. Such risks include, but are not limited to: the ability to successfully manage the leadership transition and identify and retain a permanent Chief Executive Officer; potential disruption to the business, management, employees, customers or OEM partners resulting from the leadership transition; adjustments to preliminary results arising from the completion of the Company’s financial close procedures; the impact of the divestiture of Marucci Sports on the Company’s future results of operations, including the loss of its net sales and earnings contribution; supply disruptions, including in the Powered Vehicles Group, and the availability of chassis and aluminum; inflation in aluminum, steel and freight costs and the assumption that input costs remain at current levels; the amount, timing and retention of IEEPA tariff refunds; operational challenges and higher expenses in the Aftermarket Applications Group’s upfit business; softer than expected bike demand in the Specialty Sports Group; the Company’s ability to achieve the objectives of its profit optimization program; the Company’s decision and ability to market and execute potential strategic transactions, which depend on, among other factors, third-party interest, valuation considerations and regulatory requirements; the Company’s ability to maintain its suppliers for materials, component parts and product without significant supply chain disruptions; the Company’s ability to improve operating and supply chain efficiencies; the Company’s ability to enforce its intellectual property rights; the Company’s future financial performance, including its sales, cost of sales, gross profit or gross margin, operating expenses, ability to generate positive cash flow, ability to maintain profitability, and ability to remain in compliance with financial covenants; the Company’s ability to monitor the effects of new technological applications, such as artificial intelligence; the Company’s ability to protect against cybersecurity incidents and disruptions or failures of our information technology systems; the Company’s ability to adapt its business model to mitigate the impact of certain changes in tax laws, tariffs, and international trade policies, including regulations or orders related to the import and export of industry products; changes in the relative proportion of profit earned in the numerous jurisdictions in which the Company does business and in tax legislation, case law and other authoritative guidance in those jurisdictions; factors which impact the calculation of the weighted average number of diluted shares of common stock outstanding, including the market price of the Company’s common stock, grants of equity-based awards and the vesting schedules of equity-based awards; the Company’s ability to develop new and innovative products in its current end-markets and to leverage its technologies and brand to expand into new categories and end-markets; the spread of highly infectious or contagious diseases or public health issues causing disruptions in the U.S. and global economy and disrupting the business activities and operations of the Company’s customers, business and operations; the Company’s ability to increase its aftermarket penetration; the Company’s exposure to currency exchange rate fluctuations; the loss of key customers; our ability to accurately forecast demand for our products; strategic transformation costs; legal and regulatory developments, including the outcome of pending litigation or regulatory or other governmental inquiries, and the impact of changing emissions and other regulations in the various jurisdictions in which our products are produced, used, and/or sold; the cost of compliance with, or liabilities related to, environmental or other governmental regulations or changes in governmental or industry regulatory standards; the possibility that the Company may not be able to accelerate its international growth; the Company’s ability to maintain its premium brand image and high-performance products; the Company’s ability to maintain relationships with the professional athletes and race teams that it sponsors; the possibility that the Company may not be able to selectively add additional dealers and distributors in certain geographic markets; the overall growth of the markets in which the Company competes; the Company’s expectations regarding consumer preferences and its ability to respond to changes in consumer preferences and effectively compete against competitors; changes in demand for performance-defining products as well as the Company’s other products; the Company’s loss of key personnel, management and skilled engineers; the Company’s ability to successfully identify, evaluate and manage potential acquisitions and to benefit from such acquisitions; the Company’s ability to complete any acquisition and/or incorporate any acquired assets into its business; product recalls and product liability claims; the impact of tension in China-Taiwan relations, the war in Iran, or similar events on the Company’s business, operations or supply chain; future economic or market conditions, including the impact of inflation or the U.S. Federal Reserve’s interest rate changes in response thereto; changes in commodity, freight, and tariff costs (including tariff relief or our ability to mitigate tariffs, particularly in light of the policies of the current presidential administration and retaliatory actions in response thereto); our ability to mitigate increasing input costs through pricing or other measures; and other risks and uncertainties described under “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended January 2, 2026, filed with the Securities and Exchange Commission on February 27, 2026, and in its Quarterly Reports on Form 10-Q and other subsequent filings. New risks and uncertainties emerge from time to time, and it is not possible for the Company to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this press release. Investors are cautioned not to place undue reliance on the Company’s forward-looking statements. Forward-looking statements speak only as of the date of this release, and the Company undertakes no obligation to update or revise any forward-looking statement, except as required by law.
CONTACT:
Investors:
Jeff Sonnek
646-277-1263
[email protected]
HII získala od amerického námořnictva zakázku AUKUS v hodnotě 56 milionů USD na technickou a konstrukční podporu, jejíž hodnota může vzrůst až na 91 milionů USD.
Key Takeaways HII secured a $56 million AUKUS contract, potentially rising to $91 million.HII will support submarine design, technology integration and supply-chain development.HII's nuclear shipbuilding expertise could support long-term growth under AUKUS. Huntington Ingalls Industries (HII - Free Report) is positioned to benefit from growing cooperation among the United States, the United Kingdom and Australia to strengthen undersea defense capabilities. The AUKUS partnership is creating opportunities for submarine design, engineering, technology development and supply-chain cooperation among the three nations.
HII’s Newport News Shipbuilding division plays an important role in these efforts, drawing on its experience in designing and building nuclear-powered submarines. On Oct. 13, 2026, the company announced a $56 million U.S. Navy contract for shipbuilding engineering and design support for AUKUS. An option could increase the contract’s cumulative value to $91 million.
The work includes technology integration, engineering, supply-chain development, workforce support and digital transformation. HII engineers and designers will also contribute to the design of the SSN-AUKUS nuclear-powered submarine, which is planned for construction in the United Kingdom and Australia.
Beyond this contract, HII is supporting the development of an allied submarine industrial base. Its Mission Technologies division helps Australian suppliers qualify to participate in the U.S. submarine supply chain, creating opportunities for broader industrial cooperation.
The AUKUS partnership could provide long-term work across submarine design, production support and supplier development. HII’s nuclear shipbuilding expertise and involvement across multiple parts of the initiative position it to benefit as the participating countries advance their submarine capabilities. Execution, workforce availability and supply-chain readiness will remain key to translating these opportunities into sustained growth.
Defense Stocks to Keep on the RadarGrowing investment in nuclear-powered submarines and allied naval capabilities could also benefit other defense contractors.
General Dynamics (GD - Free Report) : General Dynamics’ Electric Boat business builds Virginia-class and Columbia-class submarines for the U.S. Navy, supporting demand for nuclear submarine construction and related engineering.
BAE Systems (BAESY - Free Report) : BAE Systems is a major supplier to the U.K. defense sector and is developing advanced submarine capabilities, positioning it to participate in the United Kingdom’s broader naval modernization efforts.
The Zacks Rundown for HIIShares of HII have lost 4.5% in the past year compared with the industry’s 17.9% decline.
Image Source: Zacks Investment Research
The company's shares are trading at a discount on a relative basis, with its forward 12-month Price/Sales being 0.75X compared with its industry’s average of 2.11X.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HII’s 2026 and 2027 earnings has moved north over the past 60 days.
Image Source: Zacks Investment Research
HII stock currently carries a Zacks Rank #3 (Hold).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Key Takeaways HAE shares jumped 149.3% in a year, outperforming the industry's 26.8% decline and S&P 500's 18% gain.
HAE's Plasma and MedSurg revenues grew 7.2% and 6%, respectively, in the first quarter of fiscal 2027.
HAE raised fiscal 2027 revenue growth guidance to 5-8%, though high debt and competition remain concerns.
Haemonetics (HAE - Free Report) has witnessed strong momentum over the past year. Shares of the company have risen 149.3%, outperforming the industry’s 26.8% decline. The S&P 500 composite has increased 18% during the same time frame.
With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment.
Haemonetics provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. The company operates through two global reportable segments — Apheresis and MedSurg. Apheresis comprises Plasma and Other.
Plasma includes plasma collection devices and disposables, donor management software, anticoagulants and saline sold to plasma customers. Other includes blood collection and processing devices and disposables. MedSurg comprises Interventional Technologies and Blood Management Technologies. Interventional Technologies includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection, while Blood Management Technologies includes Hemostasis Management, Cell Salvage and Transfusion Management.
Factors Favoring HAE’s Share Price GrowthHaemonetic’s share price is trending upward, prompted by strong demand for its Plasma franchise. In the first quarter of fiscal 2027, Plasma revenues increased 7.2% on a reported basis and 8.2% organically to $155.5 million. This growth reflected double-digit disposable rise globally, including mid-20% growth in North American disposables and double-digit growth in Europe, supported by prior U.S. share gains, new international share gains and higher collection volumes. Persona PLUS is extending the NexSys PCS platform through a firmware upgrade that increases plasma yield and center productivity.
Investors are also impressed with the growth of MedSurg business. In the fiscal first quarter, MedSurg revenues increased 6.0% on a reported basis and 5.9% organically to $148.1 million. Blood Management Technologies grew 8.1% organically, with double-digit growth in Hemostasis and Transfusion Management partly offset by slower Cell Salvage capital upgrades.
Image Source: Zacks Investment Research
Transfusion Management continued to benefit from software implementations and faster customer activations, expanding the recurring revenue base. Meanwhile, Interventional Technologies returned to growth, increasing 2.8% organically as Vascular Closure grew in the low double digits. VASCADE MVP and MVP XL benefited from renewed U.S. momentum, broader utilization and the expanded MVP XL indication for sheaths up to 17F outer diameter.
Hemostasis Management remains a principal product line within Blood Management Technologies. The portfolio includes TEG 5000, TEG 6s and related hemostasis analyzers. In the first quarter of fiscal 2027, Hemostasis delivered double-digit growth, supported by mid-teens disposable growth, higher utilization across the installed base and continued share gains. The HN cartridge is expanding clinical applications and extending the company’s reach in international markets. Continued adoption of TEG 6s and broader cartridge use should sustain the franchise’s contribution to Blood Management Technologies growth.
Against this backdrop, Haemonetics raised fiscal 2027 reported revenue growth guidance to 5-8% from 4-7%. Organic revenue growth is now projected to be 4-7%, up from the prior 3-6% guidance, while the expected impact from the 53rd week remains roughly 2%.
Factors That May Offset HAE’s GainsFrom a solvency viewpoint, Haemonetics ended the fiscal first quarter with $223.4 million in cash and cash equivalents and $5 million in short-term debt. The long-term debt at the end of the quarter was $1.17 billion, indicating a highly leveraged balance sheet. Net leverage was 2.69x EBITDA. The company repaid $50 million of revolver borrowings during the quarter and another $50 million after the quarter ended. Despite progress on deleveraging, the debt load remains sizable and may constrain capital allocation flexibility.
Additionally, HAE operates in a competitive environment, both for manual and automated systems. Slower-than-expected product adoption by customers, especially the American Red Cross, might reduce the company’s revenues and profit.
A Look at HAE’s EstimatesThe Zacks Consensus Estimate for 2026 earnings per share has remained unchanged at $5.29 in the past 30 days.
The company has an estimated long-term EPS growth rate of 9.4%, in line with the industry.
Stocks to ConsiderSome better-ranked stocks in the broader medical space are Phibro Animal Health (PAHC - Free Report) , Abbott (ABT - Free Report) and Globus Medical (GMED - Free Report) .
Phibro Animal Health has an earnings yield of 9.3% compared with the industry’s 2.7% yield. Shares of the company have risen 2.6% against the industry’s 27.9% decline over the past year. PAHC’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 18.4%.
PAHC sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Abbott, carrying a Zacks Rank #2 (Buy) at present, has an earnings yield of 5.6% compared with the industry’s 2.6% yield. Its earnings beat estimates in each of the trailing four quarters, the average surprise being 0.8%. ABT shares have plunged 22.5% compared with the industry’s 27.9% decline over the past year.
Globus Medical, currently carrying a Zacks Rank #2, has an earnings yield of 6.8% against the industry’s negative 1.7% yield. Its earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 27.9%. GMED shares have rallied 32.6% compared with the industry’s 7.3% growth over the past year.
Akcie společnosti Cipher Digital Holdings během týdne klesly o 25,7 % po oznámení emise bezúročných konvertibilních dluhopisů v hodnotě 850 milionů USD a emise nových akcií.
An $850 million zero-interest convertible debt offering and a concurrent share issuance sent Cipher Digital (CIFR -3.79%) down 25.7% this week, according to data provided by S&P Global Market Intelligence.
Cipher Digital stock changed hands at $10.04 as of the close on Thursday, Oct. 15, down 25.7% from Friday, Oct. 9's close through Thursday, Oct. 15's close. Over the same period, the S&P 500 (^GSPC -0.09%) fell 0.3%, and the Nasdaq-100 was down 1.8%.
$9.66-$0.38 (-3.79%)
NASDAQ · As of 10:18 AM ET 10/16/26
Convertible debt and dilution worries spark a sell-offManagement announced a private offering of $850 million in 0.00% convertible senior notes due 2032, with an option for initial buyers to purchase up to an additional $150 million. Convertible senior notes are zero-interest debt obligations that investors can later exchange for equity, trading lower interest expenses for potential stock dilution. Concurrently, the company agreed to exchange $165.9 million of its 1.75% convertible notes due 2030 for approximately 40.7 million common shares, swapping debt obligations for immediate share dilution. The stock sits down 66.7% (as of the close on Thursday, Oct. 15) from its 52-week high of $30.14.
Cipher Digital operates industrial-scale data centers and leases high-performance computing infrastructure and Bitcoin mining sites to technology and digital asset clients. The company plans to use the net proceeds to fund capital expenditures for its Barber Lake data center expansion in Texas, where it absorbs the first $359.3 million in construction cost overruns. Adding high-performance computing capacity diversifies revenue away from volatile crypto mining toward fixed-rate corporate leases.
Cipher Digital trades at a price-to-sales (P/S) ratio of 21, sitting well above the peer average of 5.4, with Marathon Digital Holdings at 4.2, Riot Platforms at 8.4, and CleanSpark at 3.5, a premium investors will accept only if its high-performance computing conversion yields reliable rental revenue. This week's $850 million convertible debt offering sharpens dilution risks while confirming that Cipher's pivot into high-performance computing infrastructure requires capital-intensive site expansion.
What to watch next for Cipher DigitalInvestors should look toward the company's next earnings report for updated construction timelines and lease revenue metrics. The key operational milestone to monitor is whether initial rent payments from the expanded Barber Lake and Black Pearl campuses begin flowing on schedule to offset rising debt loads.
Is Cipher Digital Stock a Buy?Cipher Digital is still on track for long-term growth. The stock fell due to the additional shares to be issued as part of the convertible note offering, which dilutes shareholders' investment. The risk of owning the stock to finance the data center build-out is share dilution, but this is short-term pain for long-term gain.
The offering comes after it extended the contracted lease for its Barber Lake data center in Colorado City, Texas, from 10 to 20 years. This extension means more revenue, increasing the facility's total contracted revenue from $3.8 billion to over $9 billion.
In light of the additional $5.2 billion in revenue Cipher will generate under the new agreement, the dilution from the recent convertible note offering appears very minor. Investors can look at the sell-off as a buying opportunity.
Next catalyst to watch: The company's Q3 2026 earnings release, likely in November, where investors will look for additional data center development news.
Risk note: The primary risk stems from share dilution or cost overruns on debt-funded data center construction.
Bull points:
The 20-year Barber Lake lease amendment expands contracted long-term revenue commitment to over $9 billion.Zero-coupon convertible notes allow the company to raise $850 million without incurring immediate cash interest expenses.Transitioning capacity to high-performance computing provides predictable, long-term rental income distinct from Bitcoin price swings.Bear points:
Exchanging notes for 40.7 million common shares causes immediate equity dilution for existing shareholders.Cipher must absorb the first $359.3 million in Barber Lake construction cost overruns, increasing execution risk.The company's P/S ratio of 21.8 represents a steep premium over crypto mining peers.
AkzoNobel a Axalta nabídly ústupky, aby získaly souhlas EU s fúzí v hodnotě 25 miliard USD, včetně prodeje divize AkzoNobel pro opravy automobilových laků.
Dulux paint maker AkzoNobel (AKZO.AS) and US peer Axalta Coating Systems (AXTA.N) have offered remedies in an effort to secure EU antitrust approval for their $25 billion merger, a European Commission filing showed on Friday.
The companies put in their offer on Thursday, automatically triggering a 10 working day extension of the Commission's deadline to November. The EU competition enforcer did not provide details of the concessions in line with its policy.
The companies will offer to sell AkzoNobel's vehicle refinish business to address competition concerns and expect to secure EU clearance at the end of the preliminary review, sources told Reuters last week.
The Commission is expected to seek feedback from rivals and customers before deciding whether to give the deal the green light, demand more or open a full-scale investigation.
Axalta exclusively makes coatings, with a strong presence in the US market. BASF's (BASFn.DE) coatings business, Nippon Paint (4612.T), Sherwin-Williams (SHW.N) and Kansai Nerolac (KANE.NS) compete with AkzoNobel and Axalta.
Akcie společnosti Casey's General Stores klesly od červnového maxima o 30 %, mimo jiné kvůli zpomalení růstu tržeb ve srovnatelných prodejnách na 3,2 % ze 4,5 %.
Casey's General Stores (CASY +1.51%) is the third-largest convenience store chain and fifth-largest pizza maker (by kitchen count) in the United States, but its stock performance over the last several months has been disappointing.
Down 30% from its all-time high set in June, Casey's is in the midst of its largest pullback since the Great Recession.
CASY Price data by YCharts.
However, while Wall Street frets over short-term valuation concerns, Casey's long-term investment thesis remains intact -- and I'll be looking to add to my position on the dip.
The causes for Casey's 30% sell-off
It has been a rough few months for Casey's for a variety of reasons.
An underwhelming earnings "beat": While Casey's sailed past Wall Street's estimates with sales and earnings per share rising 24% and 28% in its fiscal 2027 first quarter (which ended July 31), a lot of that outperformance was the result of soaring gas prices and higher fuel margins. Expanding its fuel margins from $0.41 per gallon to $0.478 per gallon over the last year served its bottom line well, but it doesn't reflect the actual strength of Casey's earnings, and the feat will be hard to repeat.
Slowing inside sales growth: Rising fuel margins protected the company's earnings, but they may also have eroded its inside sales growth, which slowed to 3.2% from 4.5% last year. Furthermore, while Casey's has a growing assortment of private-label offerings, guests' ongoing shift from national brands to discounted private-label products (for example, sales of name-brand chips dropped 8% as sales of Casey's brand chips grew 16%) suggests consumers are financially stressed.
Full-year guidance unchanged: Management reiterated guidance for earnings before interest, taxes, depreciation, and amortization (EBITDA) growth of 8% to 10% in fiscal 2027, which seemed to disappoint the market. It grew EBITDA by 17% in fiscal Q1, so this would indicate a pretty sharp deceleration, though management stated it may adjust guidance when it delivers its fiscal Q2 numbers.
On top of these issues, perhaps the biggest weight on Casey's stock was its ballooning valuation.
CASY P/E and EV/EBITDA Ratio data by YCharts.
Simply put, Casey's valuation had gotten way out over its skis this summer, but now, it's trading at a much more reasonable level. Valuation isn't everything in Foolish investing, but paying nearly 50 times earnings for a steady Eddie growth stock like Casey's is a bit of a stretch, as much as I love the stock.
The bull case for Casey's remains intact
CASY Casey's General Stores$683.83+$10.20 (+1.51%)
NASDAQ · As of 10:10 AM ET 10/16/26
Now trading at 31 times earnings, Casey's looks reasonably valued again relative to its growth potential, as it plans to add at least 120 new stores this fiscal year to its existing count of 2,959. Management has proven quite adept at making smart acquisitions, a strategy that has helped the company grow from 1,978 stores in 2017. Management plans to add more than 400 stores through 2029, in line with its long-term algorithm of growing its store count by 4% annually.
Image source: Getty Images.
With roughly two-thirds of U.S. convenience stores owned by small-time operators that run one to 10 locations, Casey will have plenty of opportunities to exercise its serial acquisitiveness. This is especially true considering its success in achieving dramatic improvements in sales of prepared food and dispensed beverages at its newly acquired locations. For instance, after acquiring CEFCO Convenience Stores in November 2024, food-and-beverage sales at those locations have risen 30%. By acquiring locations with lackluster or non-existent food-and-beverage operations, Casey's generates an outsize return on investment from its M&A activity after adding its know-how and branding.
This steady expansion -- paired with Casey's 25 straight years of inside same-store sales growth -- makes the company an elite compounder. Its locations serve as the cornerstone stores in many of the small towns it operates in throughout the Midwest, so Casey's should not only prove hard to disrupt, but also capable of replicating its playbook across the country as it spreads into underserved markets within reach of its current distribution centers.
That said, while I'm bullish on Casey's General Stores over the next decade and beyond, I don't think investors necessarily need to rush in and make a huge bet on the stock today. Operationally, Casey's is great -- but its stock looks like a falling knife right now. While I will feel comfortable adding to my position in two or three tranches between now and the end of 2026, I wouldn't fault investors at all if they'd rather wait to buy until they see sustained signs that the stock's upward momentum has returned, perhaps in tandem with inside sales growth reaccelerating.
Akcie Harmony Biosciences za šest měsíců vzrostly o 27,6 %, podpořeny 24% růstem tržeb přípravku Wakix na 476,7 milionu USD v první polovině roku 2026.
Key Takeaways Harmony Biosciences shares rise 27.6% in six months, fueled by strong Wakix demand and pipeline progress.Wakix sales climb 24% to $476.7 million in the first half of 2026, supporting $1.0-$1.04B revenue target.Pipeline advances in BP-205 and EPX-100 offer growth opportunities. The going has been strong for Harmony Biosciences Holdings, Inc. (HRMY - Free Report) over the past six months. Shares of this pharmaceutical company have surged 27.6% over the said time frame against the industry’s decline of 2.2%. The stock has also outperformed the sector and the S&P 500 Index during this period.
HRMY’s robust rally has been driven by better-than-expected quarterly results, which can be attributed to robust demand for lead drug Wakix (pitolisant) and encouraging pipeline progress.
HRMY Outperforms Industry, Sector and S&P 500 Index
Image Source: Zacks Investment Research
Against this backdrop, a closer evaluation of the company’s strengths and weaknesses can help assess its attractiveness as an investment opportunity.
Wakix Drives HRMY’s Strong Revenue GrowthSustained demand for lead drug Wakix, approved for excessive daytime sleepiness in adults with narcolepsy, is driving top-line growth for the company.
Sales of the drug totaled $476.7 million in the first half of 2026, up 24% from the first half of 2025.
The average patient count rose by 450 to 8,950 in the second quarter. The growth can be attributed to strong demand for Wakix, effective commercial execution and the drug’s broad clinical utility.
With approximately 80,000 diagnosed narcolepsy patients in the United States, Wakix has significant market potential to support continued revenue growth.
HRMY remains on track to achieve its 2026 Wakix revenue guidance of $1.0-$1.04 billion.
Planned franchise expansions include gastro-resistant pitolisant tablets, with a potential launch in the first half of 2027, and high-dose pitolisant, which is being evaluated in phase III studies for narcolepsy and idiopathic hypersomnia.
Additional opportunities include a phase III study on Wakix in Prader-Willi syndrome, with top-line data expected in mid-2027.
These initiatives could broaden pitolisant's reach, extend its commercial life and support future revenue growth.
However, patent litigation and potential generic competition remain important risks.
Pipeline Progress Offers Additional Growth OpportunitiesBeyond Wakix, Harmony is advancing a diversified pipeline that could create new growth drivers.
BP-205, an investigational orexin-2 receptor agonist, is a key asset, with phase I single ascending-dose data demonstrating favorable pharmacokinetics, a half-life of approximately 25 hours and a generally favorable safety and tolerability profile.
Its potential for rapid onset and once-daily dosing supports further development, with multiple ascending-dose data expected in the fourth quarter of 2026 and phase II studies across multiple central nervous system indications scheduled to begin in mid-2027.
Meanwhile, EPX-100 (clemizole hydrochloride) is being evaluated in phase III studies for Lennox-Gastaut syndrome and Dravet syndrome, with top-line data expected in the first half of 2027.
Harmony also has $962.5 million in cash, cash equivalents and investments, providing financial flexibility to fund pipeline development and pursue business development opportunities. These programs offer meaningful long-term upside, although their commercial potential will depend on clinical outcomes and regulatory approvals.
HRMY: Valuation & EstimatesGoing by the price/sales ratio, shares currently trade at 1.98X forward sales, lower than its mean of 2.51X and the biotech industry’s value of 2.06X.
Image Source: Zacks Investment Research
The bottom-line estimate for 2026 has remained unchanged and the same for 2027 has increased 8 cents to $4.06, over the past 60 days.
Image Source: Zacks Investment Research
Invest in HRMYStrong Wakix growth, expanding pitolisant franchise, promising pipeline and solid liquidity position should maintain momentum for HRMY.
The company’s reaffirmed full-year revenue guidance of $1.0-$1.04 billion highlights Wakix’s commercial strength.
Planned launches of new pitolisant formulations and potential label expansions could further extend the franchise’s growth trajectory, while pipeline candidates BP-205 and EPX-100 offer additional long-term revenue opportunities.
HRMY’s ability to generate substantial revenues and earnings from its marketed product provides a foundation for continued investment in new growth opportunities, despite patent litigations.
However, competition in the narcolepsy market remains significant. Jazz Pharmaceuticals (JAZZ - Free Report) competes with Xywav, while Alkermes (ALKS - Free Report) markets Lumryz (following the acquisition of Avadel Pharmaceuticals plc), an extended-release sodium oxybate treatment for narcolepsy.
JAZZ reported strong growth in Xywav, with approximately 17,125 active patients on treatment at the end of the second quarter of 2026. Of these, around 11,275 had narcolepsy and 5,850 had idiopathic hypersomnia.
ALKS’s pipeline also includes alixorexton, Alkermes' novel, investigational, oral, selective orexin 2 receptor agonist in development for the treatment of narcolepsy type 1, narcolepsy type 2 and idiopathic hypersomnia.
Nevertheless, continued Wakix growth and the potential expansion of its product portfolio provide a favorable foundation for long-term growth. We recommend the stock to prospective investors, while existing shareholders should hold their positions, as we believe the company has further growth potential.
HRMY currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FTC zažalovala Hims kvůli údajnému sdílení citlivých zdravotních údajů a klamavým praktikám při účtování; akcie HIMS 29. července 2026 klesly o 14,73 % na 25 USD.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options
If you purchased or acquired securities in Hims between August 4, 2025 and July 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
[You may also click here for additional information]
New York, New York--(Newsfile Corp. - October 16, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. (""Hims" or the "Company") (NYSE: HIMS) and reminds investors of the November 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.
As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) the Company shared consumers' health information with third-party advertising platforms; (2) the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is "right for them;" (3) the foregoing conduct subjected the Company to regulatory scrutiny; (4) as a result of the foregoing, the Company was reasonably likely to incur fees and penalties; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
On July 29, 2026, during market hours, the Federal Trade Commission announced it had filed a lawsuit against Hims "alleging that the telehealth provider shared consumers' sensitive health information about medical conditions with third-party advertising platforms despite claiming its services maintain consumers' privacy and deceives users about its billing and cancellation practices." On this news, Hims's stock price fell $4.32, or 14.73%, to close at $25.00 per share on July 29, 2026, on unusually heavy trading volume.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding Hims's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
To learn more about the Hims class action, go to www.faruqilaw.com/HIMS or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).
Follow us for updates on LinkedIn, on X, or on Facebook.
Frequently Asked Questions (FAQ) for Investors Regarding the Hims Securities Class Action Lawsuit:
What is the Hims securities fraud lawsuit about?
Faruqi & Faruqi, LLP has filed a securities class action lawsuit alleging that Hims & Hers Health, Inc. (NYSE: HIMS) made materially false and misleading statements to investors during the Class Period. The complaint alleges that the Company shared consumers' sensitive health information with third-party advertising platforms despite representing that its services maintain consumer privacy, and that the Company allegedly charged consumers for prescriptions almost immediately after intake form submission while telling consumers they would first be able to consult with a medical provider. The lawsuit further alleges that this conduct subjected Hims to regulatory scrutiny and made the Company reasonably likely to incur fees and penalties. On July 29, 2026, the Federal Trade Commission announced it had filed a lawsuit against Hims alleging these practices, and on that news Hims's stock price allegedly fell $4.32, or approximately 14.73%, to close at $25.00 per share on unusually heavy trading volume. As a result of the foregoing, the complaint alleges that Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Who may be eligible to participate in the lawsuit?
Investors who purchased or otherwise acquired securities of Hims & Hers Health, Inc. (NYSE: HIMS) on the NYSE exchange between August 4, 2025 and July 29, 2026, inclusive, may be eligible to participate in this class action lawsuit. Eligibility to participate in any potential recovery is not limited to investors who seek appointment as lead plaintiff; any investor who purchased Hims securities during the Class Period may be a class member. Eligible investors are encouraged to review their trading records to determine whether their purchases fall within the defined Class Period. Investors with questions about their eligibility may wish to consult with counsel to better understand their rights and options in connection with this litigation.
What is a lead plaintiff, and how can I seek appointment?
A lead plaintiff is a court-appointed representative who serves on behalf of all class members and plays an active role in directing the litigation, including working with counsel on case strategy and settlement decisions. Any investor who purchased Hims securities during the Class Period and suffered a loss may move the court for appointment as lead plaintiff, provided that motion is filed no later than November 2, 2026. Courts typically appoint the investor or group of investors with the largest financial interest in the litigation who also satisfy the requirements of Federal Rule of Civil Procedure 23 as lead plaintiff. Importantly, an investor need not seek appointment as lead plaintiff in order to participate in or share in any recovery that may result from the litigation. Investors who do not seek lead plaintiff status retain the right to remain members of the class and benefit from any judgment or settlement.
Why should investors contact Faruqi & Faruqi, LLP?
Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased Hims securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/319254
Source: Faruqi & Faruqi LLP
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
